| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 ABCA12 NAIP SMC5 ARID1A DNAH14 MDN1 SHOC1 TOR3A DNAH8 RAD51B KIF13B EP400 DNAH10 ZNFX1 CHD7 MORC2 DNAH12 ABCA6 DDX25 HELZ2 DHX32 | 1.81e-05 | 614 | 259 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 ABCA12 NAIP SMC5 MDN1 SHOC1 TOR3A DNAH8 RAD51B KIF13B DNAH10 CHD7 MORC2 DNAH12 ABCA6 DDX25 HELZ2 DHX32 | 1.98e-05 | 441 | 259 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | CPLANE2 ABCA2 ABCA12 MTG2 NAIP SMC5 EFTUD2 TUBA1B MDN1 SHOC1 TOR3A DNAH8 AGAP3 RAD51B KIF13B DNAH10 CHD7 MORC2 GTPBP10 ENTPD4 DNAH12 ABCA6 DDX25 HELZ2 DHX32 | 2.82e-05 | 775 | 259 | 25 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | CPLANE2 ABCA2 ABCA12 MTG2 NAIP SMC5 EFTUD2 TUBA1B MDN1 SHOC1 TOR3A DNAH8 AGAP3 RAD51B KIF13B DNAH10 CHD7 MORC2 GTPBP10 ENTPD4 DNAH12 DCP1B ABCA6 DDX25 HELZ2 DHX32 | 3.82e-05 | 839 | 259 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | CPLANE2 ABCA2 ABCA12 MTG2 NAIP SMC5 EFTUD2 TUBA1B MDN1 SHOC1 TOR3A DNAH8 AGAP3 RAD51B KIF13B DNAH10 CHD7 MORC2 GTPBP10 ENTPD4 DNAH12 DCP1B ABCA6 DDX25 HELZ2 DHX32 | 3.89e-05 | 840 | 259 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | CPLANE2 ABCA2 ABCA12 MTG2 NAIP SMC5 EFTUD2 TUBA1B MDN1 SHOC1 TOR3A DNAH8 AGAP3 RAD51B KIF13B DNAH10 CHD7 MORC2 GTPBP10 ENTPD4 DNAH12 DCP1B ABCA6 DDX25 HELZ2 DHX32 | 3.89e-05 | 840 | 259 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.08e-05 | 130 | 259 | 9 | GO:0005200 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.33e-05 | 18 | 259 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.10e-04 | 37 | 259 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | CPLANE2 MTG2 TUBA3E TUBA8 TUBA4A TUBA3C EFTUD2 TUBA1B TUBA1A AGAP3 TUBA3D TUBA1C GTPBP10 GUCY1B1 GUCY2F SLC19A1 | 2.12e-04 | 439 | 259 | 16 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | CPLANE2 MTG2 TUBA3E TUBA8 TUBA4A TUBA3C EFTUD2 TUBA1B TUBA1A AGAP3 TUBA3D TUBA1C GTPBP10 GUCY1B1 GUCY2F SLC19A1 | 2.12e-04 | 439 | 259 | 16 | GO:0019001 |
| GeneOntologyMolecularFunction | GTP binding | CPLANE2 MTG2 TUBA3E TUBA8 TUBA4A TUBA3C EFTUD2 TUBA1B TUBA1A AGAP3 TUBA3D TUBA1C GTPBP10 GUCY1B1 GUCY2F | 2.27e-04 | 397 | 259 | 15 | GO:0005525 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.43e-04 | 28 | 259 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | U5 snRNA binding | 4.98e-04 | 3 | 259 | 2 | GO:0030623 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 8.74e-04 | 15 | 259 | 3 | GO:0052650 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 8.74e-04 | 15 | 259 | 3 | GO:0008020 | |
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 9.88e-04 | 4 | 259 | 2 | GO:0001642 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CPLANE2 KIAA0319L TUBA3E FYCO1 TUBA8 TUBA4A TUBA3C DNAH14 CFAP65 CEP350 DNAAF5 TUBA1B CCDC13 SUGT1 ALMS1 TUBA1A SLAIN1 DNAH8 KIF13B ANK3 DNAH10 TUBA3D TUBA1C NUMA1 APOB TACC2 SPECC1L TUBGCP6 DNAH12 DNAI4 HYDIN | 8.30e-06 | 1058 | 256 | 31 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CPLANE2 TUBA3E TUBA8 TUBA4A TUBA3C CFAP65 CEP350 DNAAF5 TUBA1B CCDC13 SUGT1 ALMS1 TUBA1A SLAIN1 DNAH8 ANK3 TUBA3D TUBA1C NUMA1 TACC2 SPECC1L TUBGCP6 DNAI4 HYDIN | 1.19e-05 | 720 | 256 | 24 | GO:0000226 |
| GeneOntologyCellularComponent | microtubule | TUBA3E TUBA8 TUBA4A TUBA3C DNAH14 TUBA1B TUBA1A SVIL SLAIN1 DNAH8 KIF13B DNAH10 TUBA3D TUBA1C NUMA1 TUBGCP6 DNAH12 CEP57 | 1.39e-04 | 533 | 261 | 18 | GO:0005874 |
| GeneOntologyCellularComponent | costamere | 1.46e-04 | 22 | 261 | 4 | GO:0043034 | |
| GeneOntologyCellularComponent | nuclear RNA-directed RNA polymerase complex | 1.55e-04 | 2 | 261 | 2 | GO:0031380 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.44e-04 | 25 | 261 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 2.86e-04 | 26 | 261 | 4 | GO:0097381 | |
| GeneOntologyCellularComponent | RNA-directed RNA polymerase complex | 4.62e-04 | 3 | 261 | 2 | GO:0031379 | |
| GeneOntologyCellularComponent | RAVE complex | 4.62e-04 | 3 | 261 | 2 | GO:0043291 | |
| GeneOntologyCellularComponent | dynein complex | 5.61e-04 | 54 | 261 | 5 | GO:0030286 | |
| Domain | Alpha_tubulin | 2.79e-12 | 9 | 254 | 7 | IPR002452 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.14e-08 | 22 | 254 | 7 | IPR018316 | |
| Domain | Tubulin_C | 1.14e-08 | 22 | 254 | 7 | SM00865 | |
| Domain | Tubulin_C | 1.14e-08 | 22 | 254 | 7 | PF03953 | |
| Domain | Tubulin_C | 1.61e-08 | 23 | 254 | 7 | IPR023123 | |
| Domain | TUBULIN | 1.61e-08 | 23 | 254 | 7 | PS00227 | |
| Domain | Tubulin | 1.61e-08 | 23 | 254 | 7 | SM00864 | |
| Domain | Tub_FtsZ_C | 1.61e-08 | 23 | 254 | 7 | IPR008280 | |
| Domain | Tubulin | 1.61e-08 | 23 | 254 | 7 | IPR000217 | |
| Domain | Tubulin_CS | 1.61e-08 | 23 | 254 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 2.25e-08 | 24 | 254 | 7 | IPR003008 | |
| Domain | Tubulin | 2.25e-08 | 24 | 254 | 7 | PF00091 | |
| Domain | - | 1.97e-07 | 20 | 254 | 6 | 3.30.1330.20 | |
| Domain | - | 2.73e-07 | 21 | 254 | 6 | 1.10.287.600 | |
| Domain | - | 3.71e-07 | 22 | 254 | 6 | 3.40.50.1440 | |
| Domain | AAA+_ATPase | ABCA2 ABCA12 NAIP MDN1 DNAH8 RAD51B DNAH10 DNAH12 ABCA6 HELZ2 | 2.82e-05 | 144 | 254 | 10 | IPR003593 |
| Domain | AAA | ABCA2 ABCA12 NAIP MDN1 DNAH8 RAD51B DNAH10 DNAH12 ABCA6 HELZ2 | 2.82e-05 | 144 | 254 | 10 | SM00382 |
| Domain | ATPase_dyneun-rel_AAA | 3.00e-05 | 14 | 254 | 4 | IPR011704 | |
| Domain | AAA_8 | 3.00e-05 | 14 | 254 | 4 | PF12780 | |
| Domain | AAA_5 | 3.00e-05 | 14 | 254 | 4 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.00e-05 | 14 | 254 | 4 | IPR024317 | |
| Domain | - | CPLANE2 ABCA2 ABCA12 MTG2 NAIP SMC5 DNAH14 EFTUD2 MDN1 NLRC5 TOR3A DNAH8 AGAP3 RAD51B EP400 DNAH10 ZNFX1 CHD7 GTPBP10 DNAH12 ABCA6 DDX25 HELZ2 DHX32 HYDIN | 3.22e-05 | 746 | 254 | 25 | 3.40.50.300 |
| Domain | DHC_fam | 4.05e-05 | 15 | 254 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 4.05e-05 | 15 | 254 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.05e-05 | 15 | 254 | 4 | IPR004273 | |
| Domain | ARM-type_fold | CEP104 CAND1 TSC2 ARID1A DNAAF5 PI4KA ANKAR TARBP1 MROH9 VEPH1 SCYL3 ZNFX1 APOB RALGAPA2 PPP2R5B | 6.67e-05 | 339 | 254 | 15 | IPR016024 |
| Domain | P-loop_NTPase | CPLANE2 ABCA2 ABCA12 MTG2 NAIP SMC5 DNAH14 EFTUD2 MDN1 NLRC5 TOR3A DNAH8 AGAP3 RAD51B KIF13B EP400 DNAH10 ZNFX1 CHD7 GTPBP10 DNAH12 ABCA6 DDX25 HELZ2 DHX32 HYDIN | 9.74e-05 | 848 | 254 | 26 | IPR027417 |
| Domain | Laminin_G | 1.34e-04 | 58 | 254 | 6 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 1.56e-04 | 38 | 254 | 5 | PS50025 | |
| Domain | GTP1_OBG | 1.84e-04 | 2 | 254 | 2 | PF01018 | |
| Domain | Big_2 | 1.84e-04 | 2 | 254 | 2 | PF02368 | |
| Domain | Invasin/intimin_cell_adhesion | 1.84e-04 | 2 | 254 | 2 | IPR008964 | |
| Domain | - | 1.84e-04 | 2 | 254 | 2 | 2.70.210.12 | |
| Domain | GTP1_OBG_dom | 1.84e-04 | 2 | 254 | 2 | IPR006169 | |
| Domain | Rav1p_C | 1.84e-04 | 2 | 254 | 2 | PF12234 | |
| Domain | GTP-bd_Obg/CgtA | 1.84e-04 | 2 | 254 | 2 | IPR014100 | |
| Domain | Rav1p_C | 1.84e-04 | 2 | 254 | 2 | IPR022033 | |
| Domain | BID_2 | 1.84e-04 | 2 | 254 | 2 | SM00635 | |
| Domain | Big_2 | 1.84e-04 | 2 | 254 | 2 | IPR003343 | |
| Domain | PapD-like | 1.97e-04 | 9 | 254 | 3 | IPR008962 | |
| Domain | Laminin_G_2 | 1.99e-04 | 40 | 254 | 5 | PF02210 | |
| Domain | LamG | 3.15e-04 | 44 | 254 | 5 | SM00282 | |
| Domain | - | 3.16e-04 | 95 | 254 | 7 | 2.60.120.200 | |
| Domain | ABC_A | 4.99e-04 | 12 | 254 | 3 | IPR026082 | |
| Domain | Opsin_red/grn | 5.48e-04 | 3 | 254 | 2 | IPR000378 | |
| Domain | Vitellinogen_superhlx | 5.48e-04 | 3 | 254 | 2 | IPR011030 | |
| Domain | PLC-beta_C | 5.48e-04 | 3 | 254 | 2 | PF08703 | |
| Domain | PLC-beta_C | 5.48e-04 | 3 | 254 | 2 | IPR014815 | |
| Domain | Cadherin_CS | 7.27e-04 | 109 | 254 | 7 | IPR020894 | |
| Domain | MT | 8.10e-04 | 14 | 254 | 3 | PF12777 | |
| Domain | Dynein_HC_stalk | 8.10e-04 | 14 | 254 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 8.10e-04 | 14 | 254 | 3 | IPR013602 | |
| Domain | DHC_N2 | 8.10e-04 | 14 | 254 | 3 | PF08393 | |
| Domain | CADHERIN_1 | 9.00e-04 | 113 | 254 | 7 | PS00232 | |
| Domain | Cadherin | 9.00e-04 | 113 | 254 | 7 | PF00028 | |
| Domain | - | 9.48e-04 | 114 | 254 | 7 | 2.60.40.60 | |
| Domain | CADHERIN_2 | 9.48e-04 | 114 | 254 | 7 | PS50268 | |
| Domain | CA | 9.98e-04 | 115 | 254 | 7 | SM00112 | |
| Domain | PLCYc | 1.00e-03 | 15 | 254 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.00e-03 | 15 | 254 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 1.00e-03 | 15 | 254 | 3 | PS50008 | |
| Domain | EF-hand_like | 1.00e-03 | 15 | 254 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 1.00e-03 | 15 | 254 | 3 | PF00387 | |
| Domain | PI-PLC_fam | 1.00e-03 | 15 | 254 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.00e-03 | 15 | 254 | 3 | IPR015359 | |
| Domain | Cadherin-like | 1.05e-03 | 116 | 254 | 7 | IPR015919 | |
| Domain | KCL_cotranspt | 1.09e-03 | 4 | 254 | 2 | IPR000076 | |
| Domain | PLC-beta | 1.09e-03 | 4 | 254 | 2 | IPR016280 | |
| Domain | Cadherin | 1.16e-03 | 118 | 254 | 7 | IPR002126 | |
| Domain | PLCXc | 1.74e-03 | 18 | 254 | 3 | SM00148 | |
| Domain | PI-PLC-X | 1.74e-03 | 18 | 254 | 3 | PF00388 | |
| Domain | PIPLC_X_DOMAIN | 2.05e-03 | 19 | 254 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 2.05e-03 | 19 | 254 | 3 | IPR000909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH8 DNAH10 TUBA3D TUBA1C DNAH12 | 4.93e-12 | 43 | 182 | 11 | M47669 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH8 DNAH10 TUBA3D TUBA1C DNAH12 | 8.50e-12 | 45 | 182 | 11 | M47670 |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.46e-11 | 17 | 182 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.59e-11 | 18 | 182 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.43e-11 | 19 | 182 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.43e-11 | 19 | 182 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C TUBGCP6 | 4.57e-11 | 28 | 182 | 9 | M47898 |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 7.30e-11 | 20 | 182 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 7.30e-11 | 20 | 182 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.17e-10 | 21 | 182 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.17e-10 | 21 | 182 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.81e-10 | 22 | 182 | 8 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C TUBGCP6 | 2.41e-10 | 33 | 182 | 9 | M47901 |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 2.75e-10 | 23 | 182 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 2.75e-10 | 23 | 182 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.75e-10 | 23 | 182 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 4.08e-10 | 24 | 182 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.08e-10 | 24 | 182 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 5.93e-10 | 25 | 182 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.93e-10 | 25 | 182 | 8 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 8.48e-10 | 26 | 182 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 8.48e-10 | 26 | 182 | 8 | M47672 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 2.25e-09 | 29 | 182 | 8 | M27948 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A TUBA3D TUBA1C NUMA1 TUBGCP6 CEP57 | 3.21e-09 | 95 | 182 | 12 | M6729 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 5.34e-09 | 32 | 182 | 8 | M27491 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 5.34e-09 | 32 | 182 | 8 | M29848 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C VASH2 | 5.97e-09 | 46 | 182 | 9 | M27828 |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 6.97e-09 | 33 | 182 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.16e-08 | 35 | 182 | 8 | M47774 | |
| Pathway | KEGG_GAP_JUNCTION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PLCB2 PLCB3 TUBA3D TUBA1C GUCY1B1 | 2.11e-08 | 90 | 182 | 11 | M4013 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.32e-08 | 38 | 182 | 8 | M14981 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.69e-08 | 17 | 182 | 6 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 6.52e-08 | 43 | 182 | 8 | M47773 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.89e-08 | 44 | 182 | 8 | M27934 | |
| Pathway | REACTOME_AGGREPHAGY | 7.89e-08 | 44 | 182 | 8 | M29830 | |
| Pathway | REACTOME_KINESINS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A KIF13B TUBA3D TUBA1C | 7.96e-08 | 61 | 182 | 9 | M977 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.90e-07 | 49 | 182 | 8 | M891 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | TUBA8 TUBA4A TUBA1B ALMS1 TUBA1A TUBA3D TUBA1C NUMA1 TUBGCP6 CEP57 | 2.35e-07 | 90 | 182 | 10 | MM14979 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.62e-07 | 51 | 182 | 8 | M26972 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C RALGAPA2 | 3.46e-07 | 72 | 182 | 9 | M26954 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.57e-07 | 53 | 182 | 8 | M27651 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A TUBA3D TUBA1C NUMA1 CENPU TUBGCP6 PPP2R5B CEP57 | 4.02e-07 | 204 | 182 | 14 | M4217 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 4.80e-07 | 55 | 182 | 8 | M39613 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C NUP35 | 5.54e-07 | 76 | 182 | 9 | M27215 |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 5.54e-07 | 56 | 182 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 6.37e-07 | 57 | 182 | 8 | M27251 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.01e-06 | 27 | 182 | 6 | MM15674 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.01e-06 | 27 | 182 | 6 | MM15549 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.58e-06 | 29 | 182 | 6 | MM15219 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.92e-06 | 32 | 182 | 6 | MM14730 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | ERBB4 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C | 3.39e-06 | 94 | 182 | 9 | M2843 |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 3.52e-06 | 71 | 182 | 8 | M39690 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA3E TUBA8 ITGAV TUBA4A TUBA3C TUBA1B TUBA1A ANK3 TUBA3D TUBA1C | 3.69e-06 | 121 | 182 | 10 | M872 |
| Pathway | BIOCARTA_MTA3_PATHWAY | 4.50e-06 | 20 | 182 | 5 | MM1383 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A KIF13B TUBA3D TUBA1C | 5.67e-06 | 100 | 182 | 9 | M27650 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CENPU PPP2R5B | 5.70e-06 | 127 | 182 | 10 | M27181 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 5.90e-06 | 76 | 182 | 8 | M48037 | |
| Pathway | REACTOME_AGGREPHAGY | 6.02e-06 | 36 | 182 | 6 | MM15669 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 6.68e-06 | 102 | 182 | 9 | M27648 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 7.11e-06 | 37 | 182 | 6 | MM15102 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 7.90e-06 | 79 | 182 | 8 | M27743 | |
| Pathway | REACTOME_KINESINS | 8.17e-06 | 57 | 182 | 7 | MM15714 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A NUP210 TUBA3D TUBA1C NUP35 | 1.19e-05 | 138 | 182 | 10 | M29805 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA8 TUBA4A TUBA1B ALMS1 TUBA1A TUBA3D TUBA1C NUMA1 CENPU TUBGCP6 PPP2R5B CEP57 | 1.22e-05 | 202 | 182 | 12 | MM15362 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CENPU PPP2R5B | 1.35e-05 | 140 | 182 | 10 | M27550 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | ERBB4 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PLCB2 PLCB3 CHRNA9 TUBA3D TUBA1C | 1.42e-05 | 205 | 182 | 12 | M752 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.00e-05 | 44 | 182 | 6 | MM14606 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.08e-05 | 90 | 182 | 8 | M29841 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A NUP210 TUBA3D TUBA1C NUP35 | 2.62e-05 | 151 | 182 | 10 | M550 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.66e-05 | 68 | 182 | 7 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.66e-05 | 68 | 182 | 7 | MM14968 | |
| Pathway | REACTOME_M_PHASE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A NUP210 TUBA3D TUBA1C NUMA1 CENPU NUP35 TUBGCP6 PPP2R5B LPIN2 CEP57 | 2.88e-05 | 417 | 182 | 17 | M27662 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.34e-05 | 48 | 182 | 6 | MM15353 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 3.87e-05 | 98 | 182 | 8 | M776 | |
| Pathway | REACTOME_HCMV_INFECTION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A NUP210 TUBA3D TUBA1C NUP35 | 4.78e-05 | 162 | 182 | 10 | M29804 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.30e-05 | 52 | 182 | 6 | MM14949 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A TUBA3D TUBA1C TUBGCP6 CEP57 | 5.76e-05 | 200 | 182 | 11 | M864 |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A KIF13B TUBA3D TUBA1C | 5.97e-05 | 134 | 182 | 9 | M27751 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 6.59e-05 | 54 | 182 | 6 | M27482 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A RAD51B KIF13B TUBA3D TUBA1C | 7.18e-05 | 170 | 182 | 10 | M941 |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.28e-04 | 116 | 182 | 8 | MM15715 | |
| Pathway | REACTOME_M_PHASE | TUBA8 TUBA4A TUBA1B ALMS1 TUBA1A NUP210 TUBA3D TUBA1C NUMA1 CENPU NUP35 TUBGCP6 PPP2R5B LPIN2 CEP57 | 1.51e-04 | 387 | 182 | 15 | MM15364 |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CENPU PPP2R5B | 1.88e-04 | 191 | 182 | 10 | M29614 |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.92e-04 | 156 | 182 | 9 | M27097 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | ERBB4 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A PLCB2 PLCB3 CHRNA9 TUBA3D TUBA1C | 2.03e-04 | 270 | 182 | 12 | M15514 |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.04e-04 | 66 | 182 | 6 | MM17074 | |
| Pathway | REACTOME_AUTOPHAGY | 2.11e-04 | 158 | 182 | 9 | M27935 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A NUP210 TUBA3D TUBA1C NUP35 IFNAR1 SMAD7 | 2.25e-04 | 273 | 182 | 12 | M983 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.27e-04 | 126 | 182 | 8 | M705 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C CENPU NUP35 PPP2R5B | 2.49e-04 | 236 | 182 | 11 | M27185 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.67e-04 | 129 | 182 | 8 | MM14894 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.74e-04 | 98 | 182 | 7 | MM15352 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A TUBA3D TUBA1C CEP57 | 2.84e-04 | 201 | 182 | 10 | M27472 |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 3.24e-04 | 11 | 182 | 3 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 3.24e-04 | 11 | 182 | 3 | MM15035 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A NUP210 TUBA3D TUBA1C NUMA1 CENPU NUP35 TUBGCP6 PPP2R5B LPIN2 RPA1 CEP57 | 3.49e-04 | 561 | 182 | 18 | M5336 |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 3.55e-04 | 73 | 182 | 6 | MM15672 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.55e-04 | 73 | 182 | 6 | MM15491 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B ALMS1 TUBA1A APOO TUBA3D TUBA1C HELZ2 CEP57 | 4.82e-04 | 297 | 182 | 12 | M27050 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.87e-04 | 141 | 182 | 8 | MM15266 | |
| Pubmed | 8.59e-17 | 9 | 263 | 8 | 21167302 | ||
| Pubmed | 6.76e-13 | 19 | 263 | 8 | 15698476 | ||
| Pubmed | 6.76e-13 | 19 | 263 | 8 | 15691386 | ||
| Pubmed | 2.80e-12 | 22 | 263 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 4.88e-12 | 8 | 263 | 6 | 16148047 | |
| Pubmed | EFTUD2 CEP350 PRR12 UBE4A FAT2 ALMS1 SACS NUP210 TXNDC16 ADGRF5 MGA TASOR KIF13B DMXL2 NELFB ZDHHC5 MORC2 RALGAPA2 ABLIM3 SBF2 HELZ2 PALLD MAST3 | 5.23e-12 | 493 | 263 | 23 | 15368895 | |
| Pubmed | 1.42e-10 | 6 | 263 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.42e-10 | 6 | 263 | 5 | 7651436 | |
| Pubmed | 1.42e-10 | 6 | 263 | 5 | 16327313 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.57e-10 | 12 | 263 | 6 | 15331610 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 2.02e-10 | 22 | 263 | 7 | 23826228 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 2.90e-10 | 13 | 263 | 6 | 10908577 | |
| Pubmed | CAND1 KIAA0319L RYR2 DMXL1 EFTUD2 CEP350 SUGT1 PI4KA MGA TASOR AGAP3 FAT4 ANK3 EP400 TUBA1C SCYL3 NELFB ZDHHC5 APOB SPECC1L GSTP1 PPP2R3A ZBED6 SLC19A1 ZFHX3 FAM219A | 3.11e-10 | 777 | 263 | 26 | 35844135 | |
| Pubmed | 4.94e-10 | 7 | 263 | 5 | 11146551 | ||
| Pubmed | 5.04e-10 | 14 | 263 | 6 | 12486001 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 2.93e-09 | 9 | 263 | 5 | 11953448 | |
| Pubmed | 3.20e-09 | 4 | 263 | 4 | 18400243 | ||
| Pubmed | 6.46e-09 | 76 | 263 | 9 | 27542412 | ||
| Pubmed | 1.19e-08 | 22 | 263 | 6 | 15103018 | ||
| Pubmed | CAND1 ETF1 TSC2 FYCO1 TMEM132B PPM1H SLC12A5 EFTUD2 CCDC13 MDN1 PI4KA SVIL MGA KIF13B DMXL2 CAD ANK3 NUMA1 ZNFX1 CHD7 SPECC1L GRM4 ABLIM3 FXR1 RPA1 AFF4 | 2.58e-08 | 963 | 263 | 26 | 28671696 | |
| Pubmed | CAND1 NACA RDH13 ITPRID2 LENG8 PRR12 TUBA1B TRMT10C MDN1 DIMT1 PNPLA6 PI4KA TASOR AGAP3 CAD EP400 TUBA1C TOPBP1 CHD7 SPECC1L MORC2 GTPBP10 NUP35 PPP3CC ZBED6 SLC25A13 HELZ2 INTS9 ZFHX3 KDM1B EDRF1 MAN1B1 AFF4 | 4.15e-08 | 1497 | 263 | 33 | 31527615 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ITPRID2 TUBA1B TUBA1A PI4KA NUP210 MAGEC1 CAD NUMA1 ZNFX1 SPECC1L PRPF8 ARHGEF40 | 5.27e-08 | 202 | 263 | 12 | 33005030 |
| Pubmed | GCNT2 WWC2 PI4KA ARID5B MKLN1 ANKRD12 MGA SUCO TASOR PLXNB1 KIF13B ANK3 APOB TACC2 CHD7 TEC ABLIM3 SPATA1 TRNT1 FXR1 VCAN SBF2 TMEM131 KDM1B RPA1 MAN1B1 AFF4 | 7.08e-08 | 1084 | 263 | 27 | 11544199 | |
| Pubmed | 1.10e-07 | 7 | 263 | 4 | 36681692 | ||
| Pubmed | 1.37e-07 | 17 | 263 | 5 | 17360745 | ||
| Pubmed | ARID1A TUBA4A MDN1 TUBA1A ARID5B MKLN1 MAGEC1 TENT2 EP400 CHD7 MEPCE INTS9 MRPL1 | 2.80e-07 | 282 | 263 | 13 | 23667531 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CAND1 NAIP ARID1A DNAH14 PPM1H DNAAF5 PNPLA6 RIN2 ANKAR NUP210 ARID5B MKLN1 NLRC5 ANKRD12 MTARC1 AGAP3 RAD51B SLC12A6 COL5A1 ANK3 PCDH11Y DHRS7B PPP2R3A TRNT1 LATS2 SLC19A1 SBF2 ZFHX3 METTL15 MAN1B1 AFF4 | 3.83e-07 | 1489 | 263 | 31 | 28611215 |
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 11163133 | ||
| Pubmed | 4.28e-07 | 3 | 263 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 4.28e-07 | 3 | 263 | 3 | 9722999 | |
| Pubmed | SMC5 ARID1A TUBA4A PRR12 MDN1 MGA RAD51B EP400 NELFB TOPBP1 CENPU SPECC1L SLC25A13 INTS9 KDM1B RPA1 | 4.41e-07 | 453 | 263 | 16 | 29656893 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 5.02e-07 | 125 | 263 | 9 | 36030824 | |
| Pubmed | CAND1 NACA TSC2 RDH13 ITPRID2 EFTUD2 DNAAF5 UBE4A TRMT10C MDN1 DIMT1 SUGT1 TUBA1A UFD1 NUP210 COL5A1 CAD PIGS TUBA1C NUMA1 SPECC1L PRPF8 GTPBP10 ARG2 GSTP1 SLC25A13 SERPINE1 DHX32 RPA1 MRPL1 | 5.91e-07 | 1440 | 263 | 30 | 30833792 | |
| Pubmed | 7.00e-07 | 130 | 263 | 9 | 12421765 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB4 DENND4A TSC2 ITPRID2 ARHGEF17 ZYX PPM1H CEP350 WWC2 MDN1 ALMS1 CEP95 PI4KA SVIL AGAP3 KIF13B NELFB FXR1 DCP1B MEPCE PALLD EDRF1 | 8.03e-07 | 861 | 263 | 22 | 36931259 |
| Pubmed | 9.81e-07 | 100 | 263 | 8 | 10048485 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CAND1 NACA ITPRID2 TUBA4A EFTUD2 CEP350 TUBA1B MDN1 SACS PI4KA SVIL NUP210 MGA CAD EP400 TUBA1C NUMA1 SPECC1L PRPF8 NUP35 GSTP1 FXR1 SLC25A13 RPA1 | 1.15e-06 | 1024 | 263 | 24 | 24711643 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MTG2 TSC2 RDH13 ITPRID2 UBE4A TRMT10C MDN1 SUGT1 ALMS1 PI4KA SLAIN1 SUCO HSDL1 MTARC1 CAD APOO PITRM1 FNDC3A TACC2 GTPBP10 TFCP2 NUP35 ARG2 FXR1 SLC25A13 TMEM131 RPA1 METTL15 QRSL1 MRPL1 | 1.29e-06 | 1496 | 263 | 30 | 32877691 |
| Pubmed | ERBB4 ABCA12 ARID1A DIMT1 PNPLA6 ALMS1 MGA TENT2 WWC1 AGAP3 EP400 ARRDC4 FAT3 RALGAPA2 DHRS7B ARG2 TUBGCP6 ARHGEF40 FXR1 SLC25A13 CAPRIN2 MEPCE ZFHX3 KDM1B AFF4 | 1.53e-06 | 1116 | 263 | 25 | 31753913 | |
| Pubmed | 1.70e-06 | 4 | 263 | 3 | 9188725 | ||
| Pubmed | Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy. | 1.70e-06 | 4 | 263 | 3 | 29386880 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCA2 MANBA KIAA0319L TSC2 ITGAV DMXL1 SVIL NUP210 TXNDC16 TOR3A SUCO PLXNA1 PLXNB1 MTARC1 COL5A1 FAT4 COL12A1 PIGS NECTIN3 ECE1 NUP35 SERPINE1 TMEM131 PALLD MAN1B1 CD276 | 1.75e-06 | 1201 | 263 | 26 | 35696571 |
| Pubmed | DENND4A KIAA0319L TSC2 FYCO1 ITGAV DMXL1 PI4KA PLXNA1 SLC12A6 DMXL2 PIGS SCYL3 FNDC3A ECE1 NUP35 TMEM131 | 1.77e-06 | 504 | 263 | 16 | 34432599 | |
| Pubmed | CAND1 ACO1 ETF1 ITPRID2 ARID1A DNAAF5 MDN1 PNPLA6 PI4KA RIN2 SVIL RAD51B ANK3 SPECC1L DHRS7B FXR1 SLC25A13 RPA1 | 1.95e-06 | 634 | 263 | 18 | 34591612 | |
| Pubmed | ABCA2 ABCA12 TUBA3E TUBA8 TUBA4A TUBA3C ZYX EFTUD2 PRR12 TUBA1B TUBA1A FAT4 CAD APOB ASXL3 SLC25A13 | 2.23e-06 | 513 | 263 | 16 | 25798074 | |
| Pubmed | CAND1 EFTUD2 TUBA1B MDN1 PNPLA6 PI4KA CAD TUBA1C PRPF8 SLC25A13 | 2.87e-06 | 197 | 263 | 10 | 31620119 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 SETD1B MTG2 KIAA0319L TSC2 FYCO1 ARID1A PRR12 MDN1 PNPLA6 PI4KA NLRC5 PLXNA1 AGAP3 EP400 ZDHHC5 ECE1 RALGAPA2 ARHGEF40 LATS2 SBF2 HELZ2 SMAD7 CD276 | 4.22e-06 | 1105 | 263 | 24 | 35748872 |
| Pubmed | Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. | 4.23e-06 | 5 | 263 | 3 | 2937147 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DENND4A CAND1 NACA ETF1 CMYA5 EFTUD2 TUBA1B UBE4A TRMT10C MDN1 DIMT1 PI4KA NUP210 PLXNA1 CA2 CAD PITRM1 DNAH10 TUBA1C NUMA1 APOB PRPF8 TFCP2 NUP35 GSTP1 FXR1 SLC25A13 RPA1 | 4.38e-06 | 1425 | 263 | 28 | 30948266 |
| Pubmed | CAND1 MTG2 TSC2 TUBA4A DNAAF5 MDN1 PNPLA6 PI4KA NUP210 HSDL1 MTARC1 TUBA1C DHRS7B TUBGCP6 INTS9 DHX32 TMEM131 | 4.41e-06 | 606 | 263 | 17 | 36538041 | |
| Pubmed | NUP210L NACA SUGT1 PI4KA NUP210 MGA TASOR WWC1 FAT4 CAD APOO EP400 FNDC3A APOB MORC2 ECE1 PRPF8 SLC25A13 ROS1 | 5.64e-06 | 754 | 263 | 19 | 35906200 | |
| Pubmed | ABCA2 CAND1 ACO1 KIAA0319L TSC2 CMYA5 ARID1A CEP350 TUBA1B UBE4A CCDC13 SACS ARID5B MKLN1 BTG3 TARBP1 AGAP3 DMXL2 ANK3 ZNFX1 IDS PRPF8 ARG2 GUCY1B1 TMEM131 AFF4 | 5.88e-06 | 1285 | 263 | 26 | 35914814 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TUBA4A TUBA1B DIMT1 SUGT1 TUBA1A DNAH8 HSDL1 KIF13B CAD NUMA1 NELFB FNDC3A MORC2 PRPF8 NUP35 FXR1 SLC25A13 RPA1 | 8.21e-06 | 704 | 263 | 18 | 29955894 |
| Pubmed | 8.41e-06 | 6 | 263 | 3 | 18613978 | ||
| Pubmed | 8.41e-06 | 6 | 263 | 3 | 12090300 | ||
| Pubmed | 8.41e-06 | 6 | 263 | 3 | 10840040 | ||
| Pubmed | ITPRID2 EFTUD2 TUBA1B TUBA1A SVIL CAD TUBA1C SPECC1L FXR1 MEPCE RPA1 | 8.72e-06 | 274 | 263 | 11 | 34244482 | |
| Pubmed | 8.93e-06 | 177 | 263 | 9 | 26206133 | ||
| Pubmed | DENND4A NACA COLGALT2 TUBA4A PRR12 TMEM62 PLCB3 TASOR HSDL1 PLXNB1 DMXL2 ZNFX1 MORC2 ECE1 ARHGEF40 PALLD MAN1B1 | 1.10e-05 | 650 | 263 | 17 | 38777146 | |
| Pubmed | CEP104 TUBA4A ZYX TUBA1B UBE4A SUGT1 TUBA1A CAD TUBA1C NUMA1 TTC23 | 1.22e-05 | 284 | 263 | 11 | 29459677 | |
| Pubmed | CAND1 NACA TUBA3E RDH13 TUBA4A TUBA3C DNAAF5 TUBA1B TRMT10C SUGT1 TUBA1A PITRM1 TUBA1C PRPF8 NUP35 ARG2 SLC25A13 MEPCE RPA1 QRSL1 | 1.39e-05 | 878 | 263 | 20 | 37223481 | |
| Pubmed | 1.46e-05 | 7 | 263 | 3 | 16059920 | ||
| Pubmed | CAND1 RDH13 ARHGEF17 ITGAV TUBA4A ZYX DNAAF5 TUBA1B TRMT10C SUGT1 NUP210 TOR3A COL5A1 CAD COL12A1 PIGS NUMA1 APOB ECE1 PRPF8 GSTP1 ARHGEF40 RPA1 PALLD GAA | 2.02e-05 | 1297 | 263 | 25 | 33545068 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | CAND1 NACA EFTUD2 CEP350 TUBA1B TUBA1A MGA CAD EP400 NUMA1 TOPBP1 RPA1 | 2.02e-05 | 357 | 263 | 12 | 37059091 |
| Pubmed | MANBA COLGALT2 ITGAV TUBA1B TUBA1A NUP210 PLXNA1 CAD PIGS TUBA1C ECE1 PRPF8 SLC25A13 TMEM131 RPA1 GAA | 2.05e-05 | 613 | 263 | 16 | 22268729 | |
| Pubmed | Evolutionary and molecular facts link the WWC protein family to Hippo signaling. | 2.33e-05 | 8 | 263 | 3 | 24682284 | |
| Pubmed | 2.33e-05 | 8 | 263 | 3 | 1572654 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | NACA ITPRID2 TUBA4A SUGT1 TUBA1A SVIL CAD NUMA1 CHD7 SPECC1L MORC2 PRPF8 TFCP2 FXR1 SLC25A13 RPA1 | 2.64e-05 | 626 | 263 | 16 | 33644029 |
| Pubmed | ITPRID2 DMXL1 EFTUD2 UBE4A TRMT10C MDN1 PNPLA6 SUGT1 SACS PI4KA NUP210 SUCO DMXL2 CAD ANK3 TUBA1C ZDHHC5 FNDC3A PRPF8 TFCP2 TUBGCP6 SLC19A1 TMEM131 QRSL1 MRPL1 EDRF1 MAST3 | 2.64e-05 | 1487 | 263 | 27 | 33957083 | |
| Pubmed | ITGAV TUBA4A ZYX DIMT1 ARID5B MKLN1 PLCB3 MAGEC1 CAD TUBA1C APOB VWA7 DNAH12 AFF4 | 2.91e-05 | 496 | 263 | 14 | 31343991 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.22e-05 | 208 | 263 | 9 | 33230847 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | RDH13 ARHGEF17 TUBA4A TUBA3C EFTUD2 CEP350 TUBA1B TRMT10C PNPLA6 TUBA1A UFD1 CAD TUBA1C PRPF8 TUBGCP6 CEP57 | 3.37e-05 | 639 | 263 | 16 | 23443559 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NACA ETF1 ITPRID2 TUBA4A AFAP1L1 EFTUD2 TUBA1B TRMT10C DIMT1 PNPLA6 SVIL NUP210 CAD TUBA1C NUMA1 SPECC1L PRPF8 DHRS7B GSTP1 FXR1 SLC25A13 SERPINE1 HELZ2 MEPCE | 3.46e-05 | 1257 | 263 | 24 | 36526897 |
| Pubmed | 3.47e-05 | 9 | 263 | 3 | 19103752 | ||
| Pubmed | 3.47e-05 | 9 | 263 | 3 | 7589147 | ||
| Pubmed | 3.47e-05 | 9 | 263 | 3 | 10501179 | ||
| Pubmed | Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins. | 3.57e-05 | 25 | 263 | 4 | 2283726 | |
| Pubmed | 3.57e-05 | 25 | 263 | 4 | 33795534 | ||
| Pubmed | CAND1 ETF1 ARID1A ARHGEF17 TUBA4A SLC12A5 PNPLA6 NRXN2 SACS TUBA1A PI4KA SVIL HSDL1 CA2 AGAP3 SLC12A6 DMXL2 CAD ANK3 TUBA1C ZNFX1 SPECC1L ABLIM3 GSTP1 FXR1 VCAN | 3.71e-05 | 1431 | 263 | 26 | 37142655 | |
| Pubmed | TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A TUBA3D TUBA1C PRPF8 | 3.73e-05 | 212 | 263 | 9 | 23463506 | |
| Pubmed | 3.75e-05 | 120 | 263 | 7 | 27320910 | ||
| Pubmed | 3.80e-05 | 164 | 263 | 8 | 32409323 | ||
| Pubmed | 3.82e-05 | 50 | 263 | 5 | 23703321 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 SETD1B NACA ARID1A TUBA4A EFTUD2 MDN1 DIMT1 PNPLA6 SUGT1 PI4KA UFD1 MGA CAD EP400 NUMA1 CHD7 PRPF8 GSTP1 GSTZ1 ARHGEF40 FXR1 SLC25A13 RPA1 PALLD | 4.02e-05 | 1353 | 263 | 25 | 29467282 |
| Pubmed | 4.19e-05 | 26 | 263 | 4 | 8218172 | ||
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 4.38e-05 | 84 | 263 | 6 | 25670202 | |
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 4.93e-05 | 10 | 263 | 3 | 2033248 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 CAND1 ACO1 ETF1 FYCO1 EFTUD2 MDN1 UFD1 CA2 CAD ANK3 TUBA3D TUBA1C NUMA1 PRPF8 GSTZ1 ZFHX3 HYDIN | 4.94e-05 | 807 | 263 | 18 | 30575818 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TSC2 ARHGEF17 TMEM132B DNAH14 MDN1 TUBA1A CEP95 PI4KA ARID5B PLCB3 MROH9 FAT4 PCDHB12 NELFB PRPF8 ERRFI1 RPA1 | 5.23e-05 | 736 | 263 | 17 | 29676528 |
| Pubmed | NACA TSC2 TRMT10C TUBA1A TOR3A TENT2 C14orf93 CAD EP400 TUBA1C CHD7 PPP2R3A | 5.52e-05 | 396 | 263 | 12 | 26687479 | |
| Pubmed | ITPRID2 ARID1A ZYX PPM1H CEP350 TUBA1B WWC2 TRMT10C SUGT1 PI4KA SVIL NUP210 CAD ANK3 SCYL3 ZDHHC5 PPP2R3A PPP2R5B PPP3CC SBF2 RPA1 | 5.57e-05 | 1049 | 263 | 21 | 27880917 | |
| Pubmed | 5.70e-05 | 2 | 263 | 2 | 29116649 | ||
| Pubmed | CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding. | 5.70e-05 | 2 | 263 | 2 | 25555908 | |
| Pubmed | 5.70e-05 | 2 | 263 | 2 | 12761218 | ||
| Pubmed | Defective colour vision associated with a missense mutation in the human green visual pigment gene. | 5.70e-05 | 2 | 263 | 2 | 1302020 | |
| Pubmed | COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma. | 5.70e-05 | 2 | 263 | 2 | 37974070 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 5.70e-05 | 2 | 263 | 2 | 24268707 | |
| Pubmed | 5.70e-05 | 2 | 263 | 2 | 10319869 | ||
| Pubmed | Plexin-A1 and plexin-B1 specifically interact at their cytoplasmic domains. | 5.70e-05 | 2 | 263 | 2 | 12559962 | |
| Pubmed | KIBRA promotes prostate cancer cell proliferation and motility. | 5.70e-05 | 2 | 263 | 2 | 27220053 | |
| Interaction | TCP11L2 interactions | 4.53e-09 | 21 | 253 | 7 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 8.73e-08 | 19 | 253 | 6 | int:GRM7 | |
| Interaction | ATOH1 interactions | 7.17e-07 | 80 | 253 | 9 | int:ATOH1 | |
| Interaction | CD79B interactions | TSC2 TUBA4A PNPLA6 TUBA1A PI4KA TARBP1 SLC12A6 TUBA1C ENTPD4 MAN1B1 | 3.27e-06 | 122 | 253 | 10 | int:CD79B |
| Interaction | CCDC8 interactions | CAND1 NACA ITPRID2 EFTUD2 CEP350 MDN1 SACS PI4KA SVIL ARID5B CAD EP400 TUBA1C NUMA1 APOB SPECC1L PRPF8 FXR1 DNAH12 SLC25A13 RPA1 CEP57 AFF4 | 9.70e-06 | 656 | 253 | 23 | int:CCDC8 |
| Interaction | LRRC31 interactions | ITPRID2 TUBA1B TUBA1A PI4KA NUP210 MAGEC1 CAD NUMA1 ZNFX1 SPECC1L PRPF8 ARHGEF40 | 1.15e-05 | 205 | 253 | 12 | int:LRRC31 |
| Interaction | HCST interactions | TSC2 TUBA4A DNAAF5 MDN1 PNPLA6 TUBA1A HSDL1 TARBP1 DMXL2 TUBA1C NELFB SLC19A1 | 1.15e-05 | 205 | 253 | 12 | int:HCST |
| Interaction | BSG interactions | CAND1 TUBA3E TUBA8 TUBA4A TUBA3C DNAAF5 TUBA1B DHRS4 MDN1 TUBA1A TARBP1 USP50 SLC12A6 TUBA3D TUBA1C FNDC3A PRPF8 NUP35 DHRS7B SLC25A13 RPA1 METTL15 | 1.66e-05 | 631 | 253 | 22 | int:BSG |
| Interaction | DNASE2B interactions | 1.75e-05 | 44 | 253 | 6 | int:DNASE2B | |
| Interaction | PRSS50 interactions | 2.27e-05 | 46 | 253 | 6 | int:PRSS50 | |
| Interaction | ENO1 interactions | CAND1 ACO1 SMC5 C3orf20 TUBA4A EFTUD2 TUBA1A TXNDC16 DNAH8 CA2 FAT4 ANK3 NUMA1 FNDC3A ZNFX1 SPECC1L PRPF8 TFCP2 GSTP1 FXR1 ASXL3 MEPCE RPA1 | 2.77e-05 | 701 | 253 | 23 | int:ENO1 |
| Interaction | DNAJC7 interactions | TUBA8 DMXL1 UBE4A MDN1 SUGT1 SACS PI4KA SVIL BTG3 SLC12A6 DMXL2 CAD PRPF8 TUBGCP6 LATS2 RPA1 EDRF1 | 2.88e-05 | 425 | 253 | 17 | int:DNAJC7 |
| Interaction | TUBB4B interactions | CAND1 SMC5 TUBA4A TUBA3C EFTUD2 TUBA1B ALMS1 TUBA1A SLAIN1 CAD TUBA3D TUBA1C TACC2 MORC2 PRPF8 TFCP2 TTC23 ASXL3 MEPCE RPA1 | 2.90e-05 | 560 | 253 | 20 | int:TUBB4B |
| Interaction | CHKA interactions | 2.97e-05 | 15 | 253 | 4 | int:CHKA | |
| Interaction | ADAMTS4 interactions | 3.33e-05 | 72 | 253 | 7 | int:ADAMTS4 | |
| Interaction | FTL interactions | ACO1 DNAH14 DIMT1 ALMS1 SH3RF2 CEP95 BTG3 PLCB3 MGA TASOR PRPF8 ARHGEF40 VASH2 HELZ2 CEP57 | 3.67e-05 | 348 | 253 | 15 | int:FTL |
| Interaction | SUSD4 interactions | 3.69e-05 | 50 | 253 | 6 | int:SUSD4 | |
| Interaction | TUBA1C interactions | CAND1 SMC5 TUBA4A TUBA3C EFTUD2 TUBA1B TUBA1A CAD TUBA1C FNDC3A ZNFX1 PRPF8 TFCP2 FXR1 TTC23 ERRFI1 MEPCE RPA1 | 3.71e-05 | 478 | 253 | 18 | int:TUBA1C |
| Interaction | YWHAG interactions | DENND4A TSC2 ITPRID2 ARHGEF17 TUBA4A TUBA3C PPM1H AFAP1L1 EFTUD2 CEP350 WWC2 MDN1 ALMS1 CEP95 PI4KA SVIL SLAIN1 SUCO WWC1 AGAP3 KIF13B CAD NELFB SPECC1L FXR1 LATS2 DCP1B VASH2 ERRFI1 MEPCE RPA1 EDRF1 MAST3 | 4.16e-05 | 1248 | 253 | 33 | int:YWHAG |
| Interaction | YWHAH interactions | ABCA2 DENND4A TSC2 ITPRID2 ARHGEF17 PPM1H EFTUD2 CEP350 WWC2 ALMS1 CEP95 PI4KA SVIL SLAIN1 SUCO WWC1 AGAP3 KIF13B NELFB SPECC1L FXR1 LATS2 DCP1B VASH2 ERRFI1 MEPCE RPA1 PALLD EDRF1 MAST3 | 5.68e-05 | 1102 | 253 | 30 | int:YWHAH |
| Interaction | FBXO2 interactions | ABCA2 MANBA KIAA0319L B3GNT3 ITGAV NUP210 SUCO PLXNA1 NPTX2 COL12A1 PIGS NECTIN3 ECE1 TMEM131 GAA CD276 | 6.83e-05 | 411 | 253 | 16 | int:FBXO2 |
| Interaction | YWHAB interactions | DENND4A TSC2 ITPRID2 ARHGEF17 TUBA3C ZYX PPM1H AFAP1L1 EFTUD2 CEP350 WWC2 CEP95 SVIL SLAIN1 SUCO WWC1 AGAP3 KIF13B NELFB TFCP2 IFNAR1 GSTP1 DCP1B VASH2 ERRFI1 MEPCE RPA1 MAST3 | 8.00e-05 | 1014 | 253 | 28 | int:YWHAB |
| Interaction | DCDC1 interactions | 8.10e-05 | 19 | 253 | 4 | int:DCDC1 | |
| Interaction | SOCS1 interactions | 8.36e-05 | 177 | 253 | 10 | int:SOCS1 | |
| Interaction | LGALS1 interactions | ABCA2 ACO1 KIAA0319L ITGAV EFTUD2 PLXNA1 SLC12A6 FAT4 FAT3 NECTIN3 ECE1 IFNAR1 VCAN CD276 | 8.42e-05 | 332 | 253 | 14 | int:LGALS1 |
| Interaction | SLURP1 interactions | 8.76e-05 | 144 | 253 | 9 | int:SLURP1 | |
| Interaction | SIAH1 interactions | KIAA0319L TUBA8 TUBA4A TUBA3C ZYX TUBA1B TUBA1A SH3RF2 SLAIN1 LATS2 AFF4 | 1.25e-04 | 223 | 253 | 11 | int:SIAH1 |
| Interaction | CEACAM8 interactions | 1.31e-04 | 119 | 253 | 8 | int:CEACAM8 | |
| Interaction | B4GALT2 interactions | 1.31e-04 | 119 | 253 | 8 | int:B4GALT2 | |
| Interaction | GABRA1 interactions | 1.33e-04 | 152 | 253 | 9 | int:GABRA1 | |
| Cytoband | 20p11.22 | 1.02e-05 | 8 | 263 | 3 | 20p11.22 | |
| Cytoband | 5q32 | 1.49e-05 | 54 | 263 | 5 | 5q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 1.01e-04 | 80 | 263 | 5 | chr5q32 | |
| Cytoband | 7q32 | 3.44e-04 | 24 | 263 | 3 | 7q32 | |
| GeneFamily | Tubulins | 1.11e-10 | 26 | 180 | 8 | 778 | |
| GeneFamily | Dyneins, axonemal | 2.04e-05 | 17 | 180 | 4 | 536 | |
| GeneFamily | Opsin receptors | 1.51e-04 | 11 | 180 | 3 | 215 | |
| GeneFamily | ATP binding cassette subfamily A | 3.26e-04 | 14 | 180 | 3 | 805 | |
| GeneFamily | C2 and WW domain containing | 5.84e-04 | 4 | 180 | 2 | 838 | |
| GeneFamily | Cadherin related | 5.95e-04 | 17 | 180 | 3 | 24 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 8.36e-04 | 19 | 180 | 3 | 832 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 9.66e-04 | 76 | 180 | 5 | 743 | |
| GeneFamily | Zinc fingers CW-type | 2.00e-03 | 7 | 180 | 2 | 96 | |
| GeneFamily | SPOUT methyltranferase domain containing | 2.65e-03 | 8 | 180 | 2 | 1294 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.65e-03 | 8 | 180 | 2 | 281 | |
| GeneFamily | Plexins | 3.39e-03 | 9 | 180 | 2 | 683 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CAND1 SMC5 CEP350 FCHSD2 MDN1 SACS RIN2 ARID5B MKLN1 SUCO TASOR WWC1 DMXL2 TOPBP1 FNDC3A SPECC1L NECTIN3 ABLIM3 PPP2R3A FXR1 SLC25A13 SERPINE1 ZFHX3 TMEM131 SMAD7 | 1.52e-06 | 856 | 259 | 25 | M4500 |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | TUBA4A SACS TUBA1A COL5A1 CHRNA9 ARHGEF40 SLCO2A1 VCAN SERPINE1 PALLD SMAD7 | 2.51e-06 | 185 | 259 | 11 | M42503 |
| Coexpression | FOROUTAN_TGFB_EMT_UP | TUBA4A SACS TUBA1A COL5A1 CHRNA9 ARHGEF40 SLCO2A1 VCAN SERPINE1 PALLD SMAD7 | 3.59e-06 | 192 | 259 | 11 | M42501 |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.04e-05 | 76 | 259 | 7 | M13396 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_DN | 1.23e-05 | 78 | 259 | 7 | MM593 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | SMC5 CEP350 FCHSD2 MDN1 ARID5B MKLN1 TASOR WWC1 TOPBP1 FNDC3A SPECC1L PPP2R3A FXR1 SLC25A13 SERPINE1 TMEM131 | 1.82e-05 | 466 | 259 | 16 | M13522 |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 2.31e-05 | 35 | 259 | 5 | M8191 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN | 2.38e-05 | 154 | 259 | 9 | M6776 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN | 3.24e-05 | 200 | 259 | 10 | M8076 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | ITGAV ALMS1 CEP95 NUP210 NUMA1 TEC PRPF8 CD36 SLC25A13 TMEM131 | 3.24e-05 | 200 | 259 | 10 | M6254 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP | DENND4A CAND1 HERC2P3 BTG3 ANKRD12 SCYL3 NELFB FNDC3A ENTPD4 GUCY2F | 3.24e-05 | 200 | 259 | 10 | M5211 |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 3.98e-05 | 20 | 259 | 4 | M45002 | |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 3.98e-05 | 20 | 259 | 4 | MM1336 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TSC2 TMEM132B RYR2 SLC12A5 FAT2 MDN1 NRXN2 ANKAR ANKRD12 TARBP1 PLXNA1 PSD2 ANK3 IDS GRM4 ABLIM3 PPP2R3A ZGLP1 ASXL3 VCAN SBF2 CAPRIN2 VASH2 ZFHX3 HYDIN FAM219A | 4.24e-05 | 1106 | 259 | 26 | M39071 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 8.04e-05 | 180 | 259 | 9 | M8239 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP | 9.51e-05 | 184 | 259 | 9 | M3804 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 RYR2 FAT4 COL12A1 DNAH10 FAT3 APOB GUCY2F ASXL3 ROS1 HYDIN | 1.32e-08 | 184 | 262 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 RYR2 FAT4 COL12A1 DNAH10 FAT3 APOB GUCY2F ASXL3 ROS1 HYDIN | 1.32e-08 | 184 | 262 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA12 RYR2 FAT4 COL12A1 DNAH10 FAT3 APOB GUCY2F ASXL3 ROS1 HYDIN | 1.32e-08 | 184 | 262 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | ERBB4 GCNT2 CMYA5 RYR2 PXDNL SVIL ANK3 TACC2 PPP2R3A CD36 PALLD | 1.94e-08 | 191 | 262 | 11 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ERBB4 GCNT2 DNAH14 WWC2 SLAIN1 ADGRF5 WWC1 ANK3 VEPH1 TRIM71 ROS1 | 1.94e-08 | 191 | 262 | 11 | ca5669bd6f4a17471acae3eb229f845cc2e08efa |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | WWC2 SHOC1 PLCD1 PLXNA1 SERTM1 COL12A1 SLC5A9 IDS ECE1 PALLD | 1.49e-07 | 184 | 262 | 10 | c7073d1b2c4fdb154d87678b92a0629c02116972 |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | WWC2 SHOC1 PLCD1 PLXNA1 SERTM1 COL12A1 SLC5A9 IDS ECE1 PALLD | 1.49e-07 | 184 | 262 | 10 | 1ed558a88215b248431c524ea16f13d9022ae98c |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.82e-07 | 188 | 262 | 10 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | ERBB4 GCNT2 DNAH14 WWC2 SLAIN1 ADGRF5 WWC1 ANK3 VEPH1 TRIM71 | 2.10e-07 | 191 | 262 | 10 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.21e-07 | 192 | 262 | 10 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.32e-07 | 193 | 262 | 10 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ERBB4 GCNT2 DNAH14 SLAIN1 ADGRF5 WWC1 ANK3 VEPH1 ERRFI1 ROS1 | 2.32e-07 | 193 | 262 | 10 | a0ca3231992f14abcf1a6129573bace320e89d2a |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.43e-07 | 194 | 262 | 10 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-07 | 195 | 262 | 10 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.55e-07 | 195 | 262 | 10 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | ASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.07e-07 | 199 | 262 | 10 | ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.46e-07 | 159 | 262 | 9 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | B3GNT3 ADGRL4 SLC12A5 CCDC13 FAT2 ADGRF5 DMXL2 SLC25A13 DNAI4 | 1.04e-06 | 176 | 262 | 9 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-06 | 179 | 262 | 9 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | droplet-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 179 | 262 | 9 | 006f2b6887b0f1f26e58bb11c919468b62bf4d62 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | AFAP1L1 ADGRL4 ADGRF5 CA2 SLCO2A1 CD36 SERPINE1 MADCAM1 SMAD7 | 1.26e-06 | 180 | 262 | 9 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | EXD1 CFAP65 TUBA1B TUBA1A DNAH10 MORC2 SPATA1 DNAH12 CAPRIN2 | 1.26e-06 | 180 | 262 | 9 | 85fc9b164147b28545e2397d32302eea03ef6346 |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.44e-06 | 183 | 262 | 9 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.51e-06 | 184 | 262 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-06 | 137 | 262 | 8 | 0c82f815c014d01213d23b466043d6e57186dceb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-06 | 186 | 262 | 9 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-06 | 186 | 262 | 9 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | remission-Platelet|World / disease stage, cell group and cell class | 1.81e-06 | 188 | 262 | 9 | fa69f20ef6b8ce620ba342f0984d40ddf259bc3f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.89e-06 | 189 | 262 | 9 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-06 | 189 | 262 | 9 | e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-06 | 189 | 262 | 9 | ecbe079606406f47d4fc97fe1670790dda8e10de | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.89e-06 | 189 | 262 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-Trachea-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-06 | 189 | 262 | 9 | f635f3f13bced3bcf796cf55723a2df851f973fe | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-06 | 190 | 262 | 9 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.97e-06 | 190 | 262 | 9 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-06 | 191 | 262 | 9 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-06 | 191 | 262 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | AFAP1L1 TUBA1A ADGRF5 NECTIN3 ECE1 SLCO2A1 CD36 SERPINE1 ZFHX3 | 2.15e-06 | 192 | 262 | 9 | 53d438e35c14e7656585942b788459e6d843c555 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.15e-06 | 192 | 262 | 9 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.15e-06 | 192 | 262 | 9 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | AFAP1L1 TUBA1A ADGRF5 NECTIN3 ECE1 SLCO2A1 CD36 SERPINE1 ZFHX3 | 2.15e-06 | 192 | 262 | 9 | 9a1aeac3ecf31f865a23d8ee15a82aef31779089 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-06 | 192 | 262 | 9 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.34e-06 | 194 | 262 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.44e-06 | 195 | 262 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.44e-06 | 195 | 262 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-06 | 195 | 262 | 9 | 0792c1e959e933b10ae987d821ff43020dfdabad | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.54e-06 | 196 | 262 | 9 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-06 | 197 | 262 | 9 | 64d7411f1b3df4f7beeddcde367bfea366878be0 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.65e-06 | 197 | 262 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.65e-06 | 197 | 262 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ADGRF5 PLXNA1 COL5A1 COL10A1 COL12A1 ECE1 SERPINE1 ERRFI1 PALLD | 2.76e-06 | 198 | 262 | 9 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-06 | 199 | 262 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-06 | 199 | 262 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-06 | 199 | 262 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-06 | 199 | 262 | 9 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 200 | 262 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 200 | 262 | 9 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.00e-06 | 200 | 262 | 9 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.00e-06 | 200 | 262 | 9 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-06 | 200 | 262 | 9 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.00e-06 | 200 | 262 | 9 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.00e-06 | 200 | 262 | 9 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-06 | 200 | 262 | 9 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.00e-06 | 200 | 262 | 9 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 158 | 262 | 8 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 158 | 262 | 8 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 158 | 262 | 8 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.94e-06 | 160 | 262 | 8 | 60fa1c717410aad7e8647703cb416cd7617cac29 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 5.67e-06 | 163 | 262 | 8 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-06 | 164 | 262 | 8 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-06 | 164 | 262 | 8 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-06 | 165 | 262 | 8 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.08e-06 | 168 | 262 | 8 | 2d056cfbb470a088a0682576753535fb4528d48f | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.08e-06 | 168 | 262 | 8 | 2f69e248c6fab1421c0081e01e1920e6ffcde344 | |
| ToppCell | droplet-Lung-nan-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-06 | 169 | 262 | 8 | f0f97ca415aef619b8b4b1399ad5e0823267516e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.72e-06 | 170 | 262 | 8 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | droplet-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.72e-06 | 170 | 262 | 8 | 683c4aa74689791944b6f3998dba51a4456fbc49 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-06 | 171 | 262 | 8 | 5d0d6c1ff610a703ae0b834a12823c5ff9012932 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.06e-06 | 171 | 262 | 8 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-06 | 176 | 262 | 8 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.12e-05 | 179 | 262 | 8 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-05 | 180 | 262 | 8 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 181 | 262 | 8 | 2e15c46e8260bb04d8264478c19a707221996026 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.22e-05 | 181 | 262 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 182 | 262 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | remission-Platelet|remission / disease stage, cell group and cell class | 1.27e-05 | 182 | 262 | 8 | 65e2798aacd670cbc3a8c8e9d1a2f7768513bb70 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 182 | 262 | 8 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-05 | 183 | 262 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 1.32e-05 | 183 | 262 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-05 | 184 | 262 | 8 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 185 | 262 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.43e-05 | 185 | 262 | 8 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | droplet-Lung-nan-21m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 185 | 262 | 8 | 43b7345a61e31099718c9cecf194b4e9884b904b | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 185 | 262 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Lung-21m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-05 | 185 | 262 | 8 | 9c907298166e3dd65b1d1e7673a1b8d01b492bd0 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.49e-05 | 186 | 262 | 8 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 186 | 262 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.54e-05 | 187 | 262 | 8 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-05 | 187 | 262 | 8 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 187 | 262 | 8 | 11670a85db87cbb3e78022a589632173604b0940 | |
| Drug | Epothilone D | 1.70e-09 | 12 | 257 | 6 | DB01873 | |
| Drug | Epothilone B | 1.70e-09 | 12 | 257 | 6 | DB03010 | |
| Drug | amiprophosmethyl | 1.13e-06 | 31 | 257 | 6 | CID000100524 | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | B3GNT3 FCHSD2 SVIL PLCD1 RAD51B KIF13B COL5A1 C14orf93 NUMA1 XDH ENTPD4 PPP2R5B | 2.38e-06 | 195 | 257 | 12 | 7403_UP |
| Drug | NSC 89199 | 2.42e-06 | 54 | 257 | 7 | CID000003268 | |
| Drug | bromocolchicine | 3.09e-06 | 21 | 257 | 5 | CID000161518 | |
| Drug | colchifoline | 3.09e-06 | 21 | 257 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 3.09e-06 | 21 | 257 | 5 | CID000164454 | |
| Drug | SRI-3072 | 3.09e-06 | 21 | 257 | 5 | CID000493469 | |
| Drug | 2,5-hexanedione | 3.11e-06 | 56 | 257 | 7 | CID000008035 | |
| Drug | albendazole | 3.38e-06 | 37 | 257 | 6 | CID000002082 | |
| Drug | 3,4,5-trimethoxyacetophenone | 3.97e-06 | 22 | 257 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 3.97e-06 | 22 | 257 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 3.97e-06 | 22 | 257 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 3.97e-06 | 22 | 257 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 3.97e-06 | 22 | 257 | 5 | CID000023759 | |
| Drug | NSC-339672 | 3.97e-06 | 22 | 257 | 5 | CID000433930 | |
| Drug | colchiceine | 3.98e-06 | 38 | 257 | 6 | CID000010156 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 5.02e-06 | 23 | 257 | 5 | CID000006858 | |
| Drug | AC1L2P05 | 5.02e-06 | 23 | 257 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 5.02e-06 | 23 | 257 | 5 | CID000125548 | |
| Drug | NSC-373301 | 5.02e-06 | 23 | 257 | 5 | CID000341375 | |
| Drug | NSC355636 | 5.02e-06 | 23 | 257 | 5 | CID000100176 | |
| Drug | IKP104 | 5.02e-06 | 23 | 257 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 5.02e-06 | 23 | 257 | 5 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 5.02e-06 | 23 | 257 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 5.02e-06 | 23 | 257 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 5.02e-06 | 23 | 257 | 5 | CID000097865 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 5.64e-06 | 4 | 257 | 3 | DB07574 | |
| Drug | parbendazole | 6.29e-06 | 24 | 257 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 6.29e-06 | 24 | 257 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 6.29e-06 | 24 | 257 | 5 | CID000330401 | |
| Drug | NABV | 6.29e-06 | 24 | 257 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 6.29e-06 | 24 | 257 | 5 | CID000163705 | |
| Drug | moscatilin | 6.29e-06 | 24 | 257 | 5 | CID000176096 | |
| Drug | NSC-36768 | 6.29e-06 | 24 | 257 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 6.29e-06 | 24 | 257 | 5 | CID000014995 | |
| Drug | colchicide | 6.29e-06 | 24 | 257 | 5 | CID000120712 | |
| Drug | mpMap | 7.78e-06 | 25 | 257 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 7.78e-06 | 25 | 257 | 5 | CID000160263 | |
| Drug | allocolchicine | 7.78e-06 | 25 | 257 | 5 | CID000196989 | |
| Drug | 1069C85 | 7.78e-06 | 25 | 257 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 7.78e-06 | 25 | 257 | 5 | CID006438440 | |
| Drug | MDL 27048 | 7.78e-06 | 25 | 257 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 7.78e-06 | 25 | 257 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 7.78e-06 | 25 | 257 | 5 | CID000043264 | |
| Drug | CA1P | 7.78e-06 | 25 | 257 | 5 | CID006918545 | |
| Drug | peloruside A | 7.78e-06 | 25 | 257 | 5 | CID006918506 | |
| Drug | NSC142227 | 7.78e-06 | 25 | 257 | 5 | CID000073427 | |
| Drug | NSC527981 | 9.55e-06 | 26 | 257 | 5 | CID000352796 | |
| Drug | NSC332029 | 9.55e-06 | 26 | 257 | 5 | CID000100073 | |
| Drug | indibulin | 9.55e-06 | 26 | 257 | 5 | CID000002929 | |
| Drug | pironetin | 9.55e-06 | 26 | 257 | 5 | CID006438891 | |
| Drug | isaxonine | 9.55e-06 | 26 | 257 | 5 | CID000071169 | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | DIMT1 MLC1 NUP210 ARID5B PLCB2 CAD NUMA1 CHD7 SPECC1L ARHGEF40 VCAN | 1.12e-05 | 190 | 257 | 11 | 1172_DN |
| Drug | vindesine | 1.16e-05 | 68 | 257 | 7 | CID000040839 | |
| Drug | AC1L1J4H | 1.16e-05 | 27 | 257 | 5 | CID000004862 | |
| Drug | dinitroanilines | 1.16e-05 | 27 | 257 | 5 | CID000136400 | |
| Drug | NSC292222 | 1.16e-05 | 27 | 257 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 1.16e-05 | 27 | 257 | 5 | CID000178028 | |
| Drug | manganese | ERBB4 ACO1 TUBA3E ITPRID2 GCNT2 TUBA8 ITGAV TUBA4A RYR2 TUBA1B FAT2 TUBA1A CA2 CAD CHRNA9 TUBA1C FNDC3A ENTPD4 ARG2 PPP3CC GUCY1B1 GUCY2F MADCAM1 SMAD7 | 1.19e-05 | 791 | 257 | 24 | CID000023930 |
| Drug | NSC 370147 | 1.40e-05 | 28 | 257 | 5 | CID000182762 | |
| Drug | NSC72302 | 1.40e-05 | 28 | 257 | 5 | CID000118078 | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | MANBA TSC2 ZYX SVIL NUP210 ANKRD12 C14orf93 FNDC3A GSTP1 PPP2R3A LPIN2 | 1.43e-05 | 195 | 257 | 11 | 6245_UP |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | DENND4A SMC5 ARID1A PLCB3 ANKRD12 DMXL2 FAT4 POU4F2 MORC2 ECE1 MAST3 | 1.66e-05 | 198 | 257 | 11 | 5422_UP |
| Drug | bp U | 1.68e-05 | 29 | 257 | 5 | CID000368697 | |
| Drug | oxibendazole | 1.68e-05 | 29 | 257 | 5 | CID000004622 | |
| Drug | Aids106696 | 1.68e-05 | 29 | 257 | 5 | CID006475933 | |
| Drug | ddGDP | 1.68e-05 | 29 | 257 | 5 | CID000134739 | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | ABCA2 RYR2 PNPLA6 PLCD1 WWC1 RAD51B COL5A1 NUMA1 ENTPD4 PPP2R3A VASH2 | 1.73e-05 | 199 | 257 | 11 | 1705_UP |
| Drug | AC1NBBHE | 1.99e-05 | 30 | 257 | 5 | CID004490620 | |
| Drug | eleutherobin | 1.99e-05 | 30 | 257 | 5 | CID006918335 | |
| Drug | azatoxin | 1.99e-05 | 30 | 257 | 5 | CID000125383 | |
| Drug | NSC617668 | 1.99e-05 | 30 | 257 | 5 | CID000357989 | |
| Drug | citostal | 1.99e-05 | 30 | 257 | 5 | CID000018991 | |
| Drug | thiocolchicine | 1.99e-05 | 30 | 257 | 5 | CID000017648 | |
| Drug | GaCl3 | 2.05e-05 | 50 | 257 | 6 | CID000026010 | |
| Drug | Coomassie blue | 2.35e-05 | 135 | 257 | 9 | CID000019731 | |
| Drug | NSC609395 | 2.36e-05 | 31 | 257 | 5 | CID005488798 | |
| Drug | AC7700 | 2.36e-05 | 31 | 257 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 2.36e-05 | 31 | 257 | 5 | CID000032851 | |
| Drug | tropone | 2.36e-05 | 31 | 257 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 2.36e-05 | 31 | 257 | 5 | CID000122777 | |
| Drug | NSC332598 | 2.36e-05 | 31 | 257 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 2.36e-05 | 31 | 257 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 2.77e-05 | 32 | 257 | 5 | CID000003583 | |
| Drug | NSC153858 | 2.77e-05 | 32 | 257 | 5 | CID000547450 | |
| Drug | E2-3,4-Q | 2.77e-05 | 32 | 257 | 5 | CID000067402 | |
| Drug | 2-demethylcolchicine | 2.77e-05 | 32 | 257 | 5 | CID000023757 | |
| Drug | LEO275 | 3.12e-05 | 79 | 257 | 7 | CID000018140 | |
| Drug | S)-monastrol | 3.20e-05 | 54 | 257 | 6 | CID000794323 | |
| Drug | mebendazole | 3.23e-05 | 33 | 257 | 5 | CID000004030 | |
| Drug | CA4P | 3.23e-05 | 33 | 257 | 5 | CID000370232 | |
| Drug | taltobulin | 3.23e-05 | 33 | 257 | 5 | CID006918637 | |
| Drug | triethyllead | 3.75e-05 | 34 | 257 | 5 | CID006328106 | |
| Drug | NSC376450 | 3.75e-05 | 34 | 257 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 3.75e-05 | 34 | 257 | 5 | CID000161091 | |
| Drug | L-quisqualic acid | TUBA3E TUBA8 TUBA4A TUBA1A PLCB2 PLCB3 PLCD1 TUBA1C GRM4 GRM6 | 4.01e-05 | 180 | 257 | 10 | CID000001209 |
| Drug | discodermolide | 4.34e-05 | 35 | 257 | 5 | CID000643668 | |
| Drug | 2-(N-morpholino)ethanesulfonic acid | 5.41e-05 | 86 | 257 | 7 | CID000078165 | |
| Disease | microlissencephaly (implicated_via_orthology) | 2.79e-17 | 8 | 255 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 2.79e-17 | 8 | 255 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 2.79e-17 | 8 | 255 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 5.37e-11 | 27 | 255 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 2.54e-06 | 4 | 255 | 3 | DOID:0050679 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | ALMS1 PLCB2 PLCB3 HSDL1 PLXNB1 FAT4 DNAH10 GSTP1 CD36 LPIN2 ZFHX3 | 3.01e-06 | 215 | 255 | 11 | DOID:9970 (implicated_via_orthology) |
| Disease | mean corpuscular hemoglobin concentration | DENND4A SETD1B SERTAD2 TSC2 PPM1H DMXL1 ADGRL4 TSTD1 ADGRF5 PLCB3 ANKRD12 RAD51B EP400 TUBA1C ZDHHC5 ECE1 ABCA6 SLC19A1 CD36 DHX32 RPA1 CEP57 GAA SMAD7 | 3.62e-05 | 1105 | 255 | 24 | EFO_0004528 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | ARID1A NLRC5 PLCB3 TASOR MTARC1 DNAH10 MOGAT2 APOB ABCA6 HELZ2 FUT2 | 5.07e-05 | 291 | 255 | 11 | EFO_0008317, EFO_0020946 |
| Disease | familial atrial fibrillation | 6.73e-05 | 156 | 255 | 8 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.73e-05 | 156 | 255 | 8 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 6.73e-05 | 156 | 255 | 8 | C0235480 | |
| Disease | Atrial Fibrillation | 8.03e-05 | 160 | 255 | 8 | C0004238 | |
| Disease | total lipids in medium HDL measurement | 1.46e-04 | 58 | 255 | 5 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.46e-04 | 58 | 255 | 5 | EFO_0022267 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.55e-04 | 224 | 255 | 9 | EFO_0004574, EFO_0008317 | |
| Disease | cholesterol in medium HDL measurement | 1.59e-04 | 59 | 255 | 5 | EFO_0021903 | |
| Disease | phospholipids in HDL measurement | 1.86e-04 | 61 | 255 | 5 | EFO_0022293 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.16e-04 | 63 | 255 | 5 | DOID:0050866 (is_marker_for) | |
| Disease | total lipids in HDL measurement | 2.16e-04 | 63 | 255 | 5 | EFO_0022307 | |
| Disease | interleukin-18-binding protein measurement | 2.22e-04 | 3 | 255 | 2 | EFO_0020495 | |
| Disease | lipoprotein measurement | 3.09e-04 | 105 | 255 | 6 | EFO_0004732 | |
| Disease | T-Cell Lymphoma | 3.29e-04 | 16 | 255 | 3 | C0079772 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 3.43e-04 | 107 | 255 | 6 | EFO_0004614, EFO_0004615 | |
| Disease | tyrosine-protein kinase TEC measurement | 4.41e-04 | 4 | 255 | 2 | EFO_0020830 | |
| Disease | cancer antigen 19.9 measurement | 4.41e-04 | 4 | 255 | 2 | EFO_0010584 | |
| Disease | mean platelet volume | SETD1B NUP210L XNDC1N NACA RDH13 TUBA8 ADGRL4 PI4KA CCDC62 SVIL ADGRF5 TASOR RAD51B SLC12A6 PCDHGA4 TUBA1C NUMA1 CHD7 VWA7 CD36 | 6.06e-04 | 1020 | 255 | 20 | EFO_0004584 |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 8.02e-04 | 225 | 255 | 8 | EFO_0008317, EFO_0010351 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 1.09e-03 | 6 | 255 | 2 | DOID:13809 (is_marker_for) | |
| Disease | total phospholipids in lipoprotein particles measurement | 1.14e-03 | 53 | 255 | 4 | EFO_0022315 | |
| Disease | phospholipids in medium HDL measurement | 1.31e-03 | 55 | 255 | 4 | EFO_0022295 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 1.36e-03 | 94 | 255 | 5 | EFO_0008595, EFO_0010351 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.37e-03 | 303 | 255 | 9 | EFO_0004612, EFO_0020945 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 1.49e-03 | 96 | 255 | 5 | EFO_0004529, EFO_0008595 | |
| Disease | dipeptidyl peptidase 2 measurement | 1.52e-03 | 7 | 255 | 2 | EFO_0020326 | |
| Disease | Vestibular Diseases | 1.52e-03 | 7 | 255 | 2 | C0042594 | |
| Disease | atrial fibrillation | ERBB4 MANBA NACA TUBA8 CCDC62 DNAH10 PPP2R3A ZFHX3 KDM1B SMAD7 | 1.55e-03 | 371 | 255 | 10 | EFO_0000275 |
| Disease | cholesterol in IDL measurement | 1.60e-03 | 58 | 255 | 4 | EFO_0021899 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 1.71e-03 | 99 | 255 | 5 | EFO_0004574, EFO_0008595 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.78e-03 | 315 | 255 | 9 | EFO_0004612, EFO_0008591 | |
| Disease | Adenoid Cystic Carcinoma | 1.79e-03 | 100 | 255 | 5 | C0010606 | |
| Disease | red blood cell density measurement | DENND4A ACO1 SERTAD2 ADGRL4 WWC2 ADGRF5 PLCB3 TASOR RAD51B CHRNA9 EP400 DNAH10 ARHGEF40 SLC19A1 CD36 SBF2 SMAD7 | 1.80e-03 | 880 | 255 | 17 | EFO_0007978 |
| Disease | cholesteryl ester measurement | 1.87e-03 | 257 | 255 | 8 | EFO_0010351 | |
| Disease | free cholesterol in HDL measurement | 1.93e-03 | 61 | 255 | 4 | EFO_0022264 | |
| Disease | Bell's palsy | 1.95e-03 | 102 | 255 | 5 | EFO_0007167 | |
| Disease | cleft palate (implicated_via_orthology) | 2.01e-03 | 8 | 255 | 2 | DOID:674 (implicated_via_orthology) | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 2.01e-03 | 8 | 255 | 2 | DOID:5520 (is_marker_for) | |
| Disease | microcephaly (is_implicated_in) | 2.01e-03 | 8 | 255 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.04e-03 | 103 | 255 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.20e-03 | 264 | 255 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 2.58e-03 | 66 | 255 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.77e-03 | 215 | 255 | 7 | EFO_0008317, EFO_0008591 | |
| Disease | triglycerides to phosphoglycerides ratio | 2.88e-03 | 68 | 255 | 4 | EFO_0022327 | |
| Disease | susceptibility to mononucleosis measurement | 3.03e-03 | 69 | 255 | 4 | EFO_0008403 | |
| Disease | Nonorganic psychosis | 3.03e-03 | 69 | 255 | 4 | C0349204 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.14e-03 | 220 | 255 | 7 | EFO_0004529, EFO_0008317 | |
| Disease | hematocrit | EXD1 ACO1 SERTAD2 ADGRL4 PRR12 PLCB3 TASOR RAD51B CHRNA9 PITRM1 APOB DHRS7B ARHGEF40 ABCA6 SBF2 FUT2 HYDIN SMAD7 | 3.21e-03 | 1011 | 255 | 18 | EFO_0004348 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.30e-03 | 222 | 255 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.36e-03 | 71 | 255 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA12 ARID1A SLC12A5 SACS CCDC62 DNAH8 CAD APOB ADAMTSL3 ABCA6 SLC19A1 SLCO2A1 EDRF1 SMAD7 | 3.39e-03 | 702 | 255 | 14 | C0009402 |
| Disease | hippocampus molecular layer volume | 3.40e-03 | 35 | 255 | 3 | EFO_0009397 | |
| Disease | myeloid white cell count | SETD1B ETF1 NAIP GCNT2 ADGRL4 NLRC5 ADGRF5 PLCB2 PLXNB1 USP50 RAD51B DNAH10 CHD7 GUCY1B1 CD36 SBF2 ZFHX3 | 3.43e-03 | 937 | 255 | 17 | EFO_0007988 |
| Disease | phosphatidylcholine measurement | 3.44e-03 | 284 | 255 | 8 | EFO_0010226 | |
| Disease | triglycerides to total lipids in small HDL percentage | 3.54e-03 | 72 | 255 | 4 | EFO_0022336 | |
| Disease | phospholipids in large HDL measurement | 3.72e-03 | 73 | 255 | 4 | EFO_0022190 | |
| Disease | hypertension (biomarker_via_orthology) | 3.73e-03 | 227 | 255 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | N-acetylphenylalanine measurement | 3.89e-03 | 11 | 255 | 2 | EFO_0800019 | |
| Disease | N-acetylhistidine measurement | 3.89e-03 | 11 | 255 | 2 | EFO_0800022 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 3.89e-03 | 11 | 255 | 2 | OBA_2045170 | |
| Disease | Cognitive impairment | 3.89e-03 | 11 | 255 | 2 | HP_0100543 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.92e-03 | 229 | 255 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 3.99e-03 | 37 | 255 | 3 | EFO_0022281 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 4.63e-03 | 39 | 255 | 3 | EFO_0022332 | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 4.64e-03 | 12 | 255 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | metabolite measurement, body weight gain | 4.64e-03 | 12 | 255 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | cheekbone morphology measurement | 4.64e-03 | 12 | 255 | 2 | EFO_0007847 | |
| Disease | renal fibrosis (biomarker_via_orthology) | 4.64e-03 | 12 | 255 | 2 | DOID:0050855 (biomarker_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 5.01e-03 | 127 | 255 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | esterified cholesterol measurement | 5.18e-03 | 128 | 255 | 5 | EFO_0008589 | |
| Disease | hypertension (implicated_via_orthology) | 5.18e-03 | 128 | 255 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | congestive heart failure (implicated_via_orthology) | 5.34e-03 | 41 | 255 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | survival time, breast carcinoma | 5.45e-03 | 13 | 255 | 2 | EFO_0000305, EFO_0000714 | |
| Disease | intercellular adhesion molecule 5 measurement | 5.45e-03 | 13 | 255 | 2 | EFO_0008164 | |
| Disease | bipolar disorder, schizophrenia | 5.71e-03 | 42 | 255 | 3 | MONDO_0004985, MONDO_0005090 | |
| Disease | Nerve Degeneration | 5.87e-03 | 83 | 255 | 4 | C0027746 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 6.01e-03 | 312 | 255 | 8 | EFO_0004612, EFO_0010351 | |
| Disease | asthma | ACO1 ETF1 ITGAV ADGRL4 TASOR RAD51B DMXL2 THEMIS VWA7 GRM4 ADAMTSL3 SLC19A1 RORC SMAD7 | 6.07e-03 | 751 | 255 | 14 | MONDO_0004979 |
| Disease | glycodeoxycholate measurement | 6.32e-03 | 14 | 255 | 2 | EFO_0010493 | |
| Disease | eating disorder, bipolar disorder | 6.32e-03 | 14 | 255 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 6.35e-03 | 315 | 255 | 8 | EFO_0004574, EFO_0004612 | |
| Disease | lipoprotein measurement, phospholipid measurement | 6.38e-03 | 85 | 255 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | Congenital Heart Defects | 6.51e-03 | 44 | 255 | 3 | C0018798 | |
| Disease | Varicose veins | 6.82e-03 | 193 | 255 | 6 | HP_0002619 | |
| Disease | intermediate density lipoprotein measurement | 6.92e-03 | 87 | 255 | 4 | EFO_0008595 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 6.93e-03 | 45 | 255 | 3 | EFO_0022236 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 7.09e-03 | 321 | 255 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | uric acid measurement | ERBB4 GCNT2 ARID1A NRXN2 FAT4 FAT3 ZDHHC5 SLC5A9 PPP2R5B ABCA6 SBF2 RPA1 | 7.17e-03 | 610 | 255 | 12 | EFO_0004761 |
| Disease | relapsing-remitting multiple sclerosis (is_marker_for) | 7.25e-03 | 15 | 255 | 2 | DOID:2378 (is_marker_for) | |
| Disease | cancer biomarker measurement | 7.25e-03 | 15 | 255 | 2 | EFO_0005127 | |
| Disease | sporadic amyotrophic lateral sclerosis | 7.52e-03 | 140 | 255 | 5 | EFO_0001357 | |
| Disease | Bladder Neoplasm | 7.52e-03 | 140 | 255 | 5 | C0005695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YPELKEPSGFINLTS | 456 | Q0P6H9 | |
| FLNYVSSLPSTKAGP | 791 | Q13075 | |
| LESPDFQPSVAKRYV | 176 | Q15173 | |
| TYIKSPPFFENLTLD | 641 | P21399 | |
| SSNPPTLYELEKITF | 341 | Q9HBW9 | |
| AKYEQKLFLAPLPSS | 731 | Q96P47 | |
| NPEYLSEFSLKPGTV | 1281 | Q15303 | |
| YAAQPALKTQFLTTP | 3011 | Q96L91 | |
| SDPLISKSASLPAYR | 576 | O94929 | |
| SIKPFYRPLGSVNSD | 351 | Q9Y2D5 | |
| PPASQAVSLLTEYAA | 111 | Q8NCV1 | |
| QSTLAALYPPFEATA | 11 | Q8TER5 | |
| LSFTPVPKDDLYNNL | 71 | P78540 | |
| TLPPSYNTSEFLRIK | 51 | P13611 | |
| AKEFVTSAPKPSDLY | 2411 | P13611 | |
| SPTSLLIYKDAPAFN | 601 | Q6P9F0 | |
| PSAAAAYVQPFLDKS | 356 | Q9C0J9 | |
| PPFSTKVSGAYLSLL | 1621 | Q86UK0 | |
| LFKIPQISYASTAPD | 171 | Q14833 | |
| FPPFSSYEKLDITVL | 2646 | Q6V0I7 | |
| SSLLTYKLPVADVYP | 1541 | Q8N139 | |
| YKLPVADVYPLSQTF | 1546 | Q8N139 | |
| FPAATLSSYSQIEKP | 2011 | Q8TCU4 | |
| DVLLNFFPYVSPKTS | 2441 | Q8TCU4 | |
| KPTLAYPESNSRAIF | 56 | Q86XR8 | |
| PNVKETYDSSSLPAL | 376 | Q71F23 | |
| EKLFGYQSLSPEITP | 286 | Q69YQ0 | |
| SLQKIYPESFSPAIQ | 351 | Q6PIY7 | |
| PLSFYLPAASGEKVS | 256 | Q9UGM1 | |
| SAAVSLQVAAPYSKP | 131 | Q5ZPR3 | |
| VAKPFLPLSDSGVIY | 2461 | Q8TDJ6 | |
| EASPNFEKAYTLPVL | 1571 | Q6UB98 | |
| YYFSNLPPSESKDIL | 696 | Q7L7V1 | |
| SPGFSPYNVSKTALL | 176 | Q9BTZ2 | |
| VFLPPYDSKSTQRSD | 91 | Q8N5S3 | |
| PSYVPKNADVLFSSF | 2606 | Q9P2D1 | |
| IAKPFLPSSQSRAEY | 2436 | Q9Y485 | |
| QKDPSSPLYSVKTFE | 86 | Q9UHL0 | |
| LTINSYDSPPKLSAE | 1421 | Q9C0F0 | |
| DFSSYLLSEPQKPFT | 2121 | Q9C0F0 | |
| SSPLFAEPYKVTSKE | 31 | Q9UHB7 | |
| QLPSEPLVTSFTGKY | 121 | Q8NCT1 | |
| SNSKYPLPVFSTFVL | 246 | Q7Z401 | |
| LIAKSPLAPFTSFVY | 321 | O15315 | |
| PLAPFTSFVYTIKEE | 326 | O15315 | |
| LPAFFAKSATIYNPV | 306 | P0DN78 | |
| LSSVPLYFISPVANS | 321 | Q9NV88 | |
| LPAFFAKSATIYNPV | 306 | P0DN77 | |
| PFVIKPTFGNSYSLV | 391 | Q9Y5F3 | |
| RVAKVSFPSYLASPA | 371 | Q96PE2 | |
| LATPPFSRLEKLYST | 2136 | O14497 | |
| PYLSSLLQPFSDDKV | 336 | Q7Z5J8 | |
| SIPDNLPFTLEKTYG | 416 | Q9Y5G9 | |
| TIAAYLPLKAVDPSS | 636 | Q8TEM1 | |
| LPVEAFSAVFTKYPE | 296 | Q8IY17 | |
| SPGFSPYNVSKTALL | 176 | Q6PKH6 | |
| TFYPDAVSPLQASIL | 3391 | Q9NU22 | |
| FTPPDQALYLAIKSF | 461 | Q2Q1W2 | |
| VYAFPDQLTVSPAAL | 111 | Q13477 | |
| LKNTVPITFPSSYKD | 1091 | O60732 | |
| PITFPSSYKDALKDV | 1096 | O60732 | |
| PKDQIAYSDTSPFLI | 201 | Q5VT66 | |
| QLKPEQFSSYLTSPD | 641 | Q7L2J0 | |
| KYLGVQLPLAPATSF | 746 | Q8IWI9 | |
| PASLSLLTFKVYAAP | 11 | Q9BUR5 | |
| LESSSFPLPKQYLDV | 266 | Q8IX03 | |
| FPLPKQYLDVSSQTD | 271 | Q8IX03 | |
| IDFSSDIRKQPAPYV | 976 | Q9NRM7 | |
| PLTSAFYRKLAPGVS | 636 | Q86WG5 | |
| AVVKYSSAPPRTAFA | 51 | Q3B7T1 | |
| FQSTSAPYPVIKELV | 296 | Q8IZA0 | |
| SSVLKDPDSNPYSLL | 466 | P51114 | |
| YARSPFLQPKLSSDI | 136 | Q9BQS8 | |
| PSLFANKFELNTYPL | 361 | Q8N0V5 | |
| ALAPVFSTKYLKSPL | 166 | Q5W064 | |
| QYSLDVPKLFPAVSS | 776 | Q6ZU64 | |
| KTFRPALPVSYLQAE | 746 | Q96PV6 | |
| EAPATSLLNDLKYSP | 56 | Q8NHP7 | |
| PSSFDATPYIKDLFT | 556 | Q86VP6 | |
| YVFFPSLKPSSSIDE | 466 | P17181 | |
| IPSDTLSKFPAFDIY | 231 | Q9UIW2 | |
| FKYTLDPNITSAGPT | 1246 | O43157 | |
| SAPIFSKSEYFVEIP | 1656 | Q9NYQ8 | |
| VSLPKFSEPLYTFSA | 2686 | Q9NYQ8 | |
| IYDLIPEAKFPVTST | 121 | Q8IXQ8 | |
| YSSLDQSPDEKPLVA | 96 | Q8IW50 | |
| PINYFFKNSDILSSP | 531 | Q96JB1 | |
| YSKSSFILISQEPQP | 601 | Q14D04 | |
| LSALTLSTVKYEPPF | 161 | Q9P2S2 | |
| NLLPTPTKSHYTFNL | 2081 | Q6ZR08 | |
| VSYPNTLPESFTKFL | 401 | Q8WX92 | |
| SPYLAVQLPARFKNT | 1551 | P42356 | |
| SLALKYLPEVFAPNA | 1581 | Q96RT7 | |
| PVPAKRYDNVTILFS | 411 | Q02153 | |
| SPQALKSFQDFYPTL | 146 | Q6UWW0 | |
| FADSSVQKEDPAPYL | 16 | A4D1T9 | |
| EPPALLKLASIDTYS | 196 | Q8NGH3 | |
| AFPPSAIYTRKDLLQ | 261 | A6NJ78 | |
| AKTLSEYNFPQFPET | 491 | Q5TGP6 | |
| SSTDYDPFLPLANVK | 1326 | Q2PPJ7 | |
| APYSTQKSSVLPLYE | 941 | P28290 | |
| PPKYEDVVQLSASDS | 331 | Q06190 | |
| YAKDIAPPLIAFGAT | 476 | Q86WI3 | |
| FRTPSKIPYSDVNIG | 366 | Q9UKM7 | |
| PEDIPFVLKSSVNNY | 386 | Q9Y5F1 | |
| VKSPELAAQPSTYLA | 261 | Q8NBN7 | |
| RTLPFQLSSVEKDYP | 506 | Q9Y6X9 | |
| TPTLNPFTYTLRNKD | 286 | Q5JQS5 | |
| LPAFFAKSATIYNPV | 306 | P04001 | |
| YAFKASPYPVILSLE | 376 | P51178 | |
| SPPAQNLLLKSYFSE | 136 | P04062 | |
| TAYFPPVFTKELQNT | 436 | Q8WX93 | |
| SALKSYTLREPPFTL | 6 | Q8IZE3 | |
| YFPISLVKTAELDPS | 86 | Q3SYC2 | |
| IAETAFKTSPYPVIL | 396 | Q01970 | |
| LRYSSLPAKPSFVIQ | 321 | A1KZ92 | |
| SSTIIANPDIPEAYK | 396 | P27694 | |
| LPPVSIDTASYKIFV | 46 | Q9BU20 | |
| SSSAIYDNPNLIKPI | 186 | Q8IZD4 | |
| NYQLYKSVSLPSLDP | 636 | P04114 | |
| VLTKYSQPEDSLIPF | 3796 | P04114 | |
| LSTAPTIAKAPFYVN | 591 | Q711Q0 | |
| FAEPFLQEKPSSYSL | 336 | O60308 | |
| FKTLPETSLPNYATN | 16 | Q9BYI3 | |
| SIKLENPLPYSVTFS | 4851 | Q4G0P3 | |
| AKPAIADYAFTTLKP | 171 | A4D1E9 | |
| LFAIPQISYASTAPE | 166 | O15303 | |
| LKDSVAAPLLSAYYP | 211 | Q8NB78 | |
| AYVPPKDLSFSEVTS | 631 | Q99715 | |
| PTTLSEAVPYLEFIK | 421 | Q9H0R6 | |
| YRFVLPSKAFASPVE | 291 | P16671 | |
| QEYIFTTPKSVPAAL | 1036 | Q9Y2H6 | |
| LANYTLPDSPFLKIF | 306 | Q10981 | |
| PDDYKFSVPNSVLSL | 826 | Q8ND61 | |
| VPAYAKQLSPATQLA | 216 | Q9H972 | |
| FTPDSKLISKYAAPL | 791 | Q8N3K9 | |
| LDNKISYPTFSRTLP | 156 | P51841 | |
| FPYKNLPIEDITNST | 961 | P06756 | |
| AYTQFLEDPGLTKSP | 476 | Q8IYE1 | |
| FIPSSYSVKVLEDLP | 936 | Q8TDW7 | |
| TSPAAYTDALLKPSA | 801 | Q5VT06 | |
| KAFLASPEYVNLPIN | 191 | P09211 | |
| KPTISVKEAFYTAAP | 46 | Q9BZC7 | |
| PASPLAAYQKSLEET | 4296 | Q12955 | |
| EQFPFLYVSGPTLSK | 571 | Q96GE4 | |
| AQLSAPTKQLYPASA | 81 | P20908 | |
| PVFLLLVIKSSPSNY | 106 | Q9Y2A9 | |
| SKLLNSGYFESIPVP | 306 | Q6IMN6 | |
| PKSLYNPYDLQVVSA | 311 | Q0VDD8 | |
| PQSTDPLRTFKDTIY | 606 | O00462 | |
| VPVSNFTYSPDTKVL | 921 | P10253 | |
| ANAERFKVDLTPYPT | 171 | O43708 | |
| FKVDLTPYPTISSIN | 176 | O43708 | |
| KVYSSSEFLAVQPTP | 706 | O60307 | |
| NVKPSLSFYPATSVV | 736 | Q5VTH9 | |
| DVYAKTLPPRSLFQS | 756 | Q9ULL0 | |
| NYFGPVALTKALLPS | 166 | Q6IAN0 | |
| GILQAPFYTRSSPKA | 581 | P42892 | |
| KLFPYLDPFDSASQL | 376 | P22304 | |
| PTPQLAAFSASKAYL | 211 | Q3SXM5 | |
| FPSYLETVTKDILAP | 646 | Q86Y56 | |
| PEKYLQFPTSNSLLS | 521 | O94868 | |
| DLKAFSAEPLLIYPT | 546 | Q8IYK4 | |
| PNPYSSEIKAFDTRL | 2291 | Q9BYK8 | |
| LNTKLANPRYSPSVF | 3526 | Q8IVF4 | |
| LAIYAGAIKSSFAPP | 356 | Q9UHW9 | |
| KRYFPGSDPTLSVLQ | 2931 | Q9NZJ4 | |
| YQVEPSTKLFPAVFA | 1531 | Q92736 | |
| VANLPYQISSPFVFK | 126 | Q9UNQ2 | |
| ATFAAYEPLKALNPV | 646 | Q5VU65 | |
| KVESLESLYFTPIPA | 1766 | Q14980 | |
| PENSAINSKYTLPAA | 181 | Q9BZA8 | |
| YPTNSDFELKTAELP | 16 | Q14914 | |
| LAIYAGVIKSAFDPP | 291 | Q9H2X9 | |
| RKTTLSPAQLDPFYT | 146 | Q8NFH5 | |
| AAPYEKEVPLSALTN | 261 | P05121 | |
| YLKPASESPSILDAV | 256 | Q8NHC5 | |
| GYEITFSLLNPDPKS | 226 | Q96S52 | |
| LAASYLNPVKSFVPQ | 1446 | Q9NQT8 | |
| ATDSSDPLKPYQDFI | 336 | Q96Q11 | |
| SYSATAFLINKVPLP | 16 | Q96PL1 | |
| DVIFDPYAPKLTSSV | 1331 | O95425 | |
| DSLQKFSSLPAYLPT | 26 | Q14DG7 | |
| YNLFESSIRKALPPA | 146 | P42680 | |
| FSSTYLPENILVDKP | 26 | Q9UL63 | |
| EAYFAIQPRPSSEKI | 361 | Q12837 | |
| TLYLETPKPYISSSN | 141 | Q00887 | |
| PEKVSDYISPLLNFA | 146 | Q9Y227 | |
| SLLTSGPNSPFYKAL | 351 | Q5JRX3 | |
| KPDYLNLASSAAPLF | 156 | Q5SWH9 | |
| FPVSIRQPLKATAYV | 466 | Q8ND83 | |
| ELKEISSFLPPVTSY | 1171 | Q5VXU9 | |
| QAVTSYLAPPITALF | 461 | Q2M3M2 | |
| PSYLFSQDPAVTFKA | 296 | Q9UPS6 | |
| NARPAVASYPFTTLK | 246 | Q9H4K7 | |
| VQSLPLKNPFYDSSD | 56 | O95096 | |
| LKNIISSSSSYPEYP | 66 | A2A2V5 | |
| LYPQSPLLSTIAEFA | 356 | Q9BVR0 | |
| PGKYLSSVLASAPFL | 586 | Q9ULL5 | |
| SPDAFKVSLPLRTNY | 221 | P47972 | |
| AYFAIQPRPSSEKIA | 291 | Q15319 | |
| SFAPDPKYVSSKALQ | 351 | Q9UJM3 | |
| SELKLKSFAPPYALQ | 116 | Q5VX52 | |
| TYKDDIQTPKFVPSS | 326 | Q9UK61 | |
| AAASPVYQISELIFP | 166 | Q14201 | |
| FLDPIKAYLNSLSFP | 76 | Q8IZF2 | |
| PLPAKEVSYLYVNTA | 46 | Q8TED9 | |
| DPSLKPLSVSYDQAT | 41 | P00918 | |
| SSSKLYFLPEDTPQG | 71 | Q14865 | |
| LYLPLFKPSVSTSKA | 656 | Q9UJS0 | |
| TSKFPSPLVVYANIR | 601 | A8K7I4 | |
| PNTKTQFFIPYTIKS | 36 | Q03692 | |
| PFLKDTPLYTDNTAN | 386 | Q6P2Q9 | |
| PSNSPLYISILFAIS | 201 | Q92959 | |
| PSLITIFSAPNYLDV | 296 | P48454 | |
| STNPFPKDFYGTLIL | 211 | Q8N1K5 | |
| KLEFAIYPAPQVSTA | 166 | P0DPH8 | |
| VLPFTLKLPYAISTA | 181 | Q8WYP3 | |
| TSVLSLPYPFASEIN | 141 | Q9BYD6 | |
| LPYPFASEINKVAVF | 146 | Q9BYD6 | |
| SSYPIFIKSATLDNP | 336 | O15105 | |
| NSLPELSPQKYFSTL | 26 | Q9P2K2 | |
| YFTRAKISIPSLPAD | 1176 | Q6AWC2 | |
| AAFPPLYKELFSTET | 496 | P51449 | |
| PFQYVLCAATSPAVK | 66 | Q12800 | |
| DSNIYIKPFLSSAPE | 401 | Q9ULR3 | |
| ADDLLKTLAPYSSQP | 276 | Q14140 | |
| PFLDVPQALSATTYK | 501 | Q9BQI7 | |
| VFSSAKYPAPERLQE | 101 | A8MWX3 | |
| SFITPYLLGPDKNFT | 46 | P41440 | |
| IPLALYSNPSVFVDK | 866 | Q92545 | |
| KLEFAIYPAPQVSTA | 166 | P0DPH7 | |
| NEVFTVFSLPIPSKY | 206 | Q70EL3 | |
| GQPSIERFPISFKTY | 171 | Q86V25 | |
| STYKIPAFGSIPIEF | 1226 | P47989 | |
| KNYVEDIPFLSPTFN | 141 | Q9NPH0 | |
| PSISAPQKIVADSYN | 406 | P08922 | |
| KPYSLVPENTSLQFN | 1661 | P08922 | |
| DKQDYPQPSDLSTFV | 2491 | O95359 | |
| PKQFVADVKNLYPSS | 266 | Q9Y2Z0 | |
| PKDFLVSISDRYPTN | 376 | Q9UBS9 | |
| IAESAFKTSPYPIIL | 391 | Q00722 | |
| TDPSYKAQILVLTYP | 41 | P27708 | |
| PFLRPNIISGKYDST | 351 | Q9P2E3 | |
| YLQDLPTVSFGKIPS | 496 | Q8NEG5 | |
| PSKYVPVSAAAIFLV | 11 | Q9C0B5 | |
| SFSSQDPKYPVENLL | 11 | Q6ZNB5 | |
| TYSKFQPQSPDFLDI | 121 | Q92890 | |
| LPSETYFFTKAVPQL | 446 | P86452 | |
| SVSVSAPAFYAPQKK | 11 | Q15942 | |
| FPNNYVIPIFRKTSS | 431 | Q8TEC5 | |
| KLEFSIYPAPQVSTA | 166 | Q71U36 | |
| SIVPPYSENTDVFKF | 121 | Q5W5X9 | |
| KLEFAIYPAPQVSTA | 166 | Q6PEY2 | |
| NPFTPESYKKLFLQS | 156 | P0C1S8 | |
| ELYETKILPFSPEFS | 401 | Q13395 | |
| YFLNPSRSSPQEIKV | 351 | Q14139 | |
| PNDAFTLKLEVYPTS | 66 | Q9BY64 | |
| YLETPQPEKALALSF | 151 | Q9H497 | |
| SPLYTIKAFIPAIDS | 866 | Q15029 | |
| KLEFSIYPAPQVSTA | 166 | P68363 | |
| NAVIAPKSSYADKAP | 536 | Q8IY18 | |
| SPLRFEPYKAVALAS | 461 | Q9Y334 | |
| DYQTLFDPKSNPLFT | 621 | Q92547 | |
| FQIKPDSSLQIIPTY | 151 | P0C6A0 | |
| LFPKDSIIYLTADSP | 281 | Q7L0Y3 | |
| KLEFSIYPAPQVSTA | 166 | Q9BQE3 | |
| KLEFAIYPAPQVSTA | 166 | Q9NY65 | |
| KLEFSIYPAPQVSTA | 166 | P68366 | |
| ASVFAISLPYTNPSK | 866 | P49815 | |
| SKSADSLYDPFIVPK | 3446 | Q15911 | |
| PAAFQALYSAEKPKL | 56 | Q8NFU3 | |
| LPQTTAEKSPGAYFL | 21 | P82987 | |
| NIDFEPFKPINTSLY | 111 | P62495 | |
| ASYAPDAKPSDLQLS | 26 | Q15049 | |
| FALAPVVTVKYTQSP | 196 | Q5VXJ0 | |
| LEPEVAALYFPKSES | 411 | Q92539 | |
| LFVITKPDVYKSPAS | 1966 | E9PAV3 | |
| PNETATIISQYKLFP | 221 | Q9NQS3 |